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                                  ABSTRACT
    Spermatogenesis is a complex process, consisting of highly organized steps controlled by
co-action of hormones, such as fbllicle-stimulating hormone (FSH) and luteinizing hormone
(LH), and testicular somatic cells. ln newt testis, FSH stimulates spermatogonial proliferation
and differentiation into primary spermatocytes through the receptor expressed on its target
somatic cells, namely Sertoli cells. Though it is considered that the FSH effects are necessary to
be mediated by local paracrine factors, which are secreted from Sertoli cells and act directly on
sperrnatogonia within the testis, such factofs have not been identified yet. This dissertation aimed
to identify FSH-upregulated local factors and their signaling mechanism exerted directly in
spermatogonial proliferation in newt (Cynops,ru2mbogasteip testis.
    Neuregulinl (NRGI) was identified as a novel FSH-upregulated gene and panial cDNAs
encoding two different clones (newt immunoglobulin (nlg)-type and newt cysteine-rich domain
(nCRD)-type) were isolated. Expression analysis indicated that both clones were highly
expressed at spermatogonial stage than at spermatocyte stage. ln vitro FSH treatment increased
nlg-･NRGI mRNA expression markedly in somatic cells, whereas nCRD-NRGI mRNA was only
slightly increased by FSH. To elucidate the function of newt NRGI, recombinant EGF-like
domain ofNRGI (nNRGI-EGF) was added to organ and reaggregated cultures with or without
somatic cells. The data demonstrated that nNRGI promoted sperrnatogonial proliferation in all
culture systems and treatment of the cultures wnh the antibody against EGF-like domain caused
remarkable suppression of spermatogonial proliferation activated by FSH, concluding that
nNRGI plays a pivotal role in promoting spermatogonial proliferation by both direct efl}ect on
spermatogonia and indirect effect via somatic cells in newt testes.
    To identify tyrosine kinase receptors responsible fbr the NRGI signaling, several inhibitors
were used in diffbrent culture systems and the results revealed that inhibitors for ErbB2 and
ErbB4 significantly suppressed the number ofthe proliferated gemi cells induced by NRGI and
                                                                      'FSH in both organ and reaggregate culture with or without somatic cells. lmmunoblotting of
                                                     'these receptors, ErbB2 and ErbB4, in different testicular cell types and spermatogenic stages
showed their expression in both somatic and germ cells at all spermatogenic stages from early
spermatogonia to primary spermatoyte stage. Furthermore, as the ligand binding to ErbB
receptors induces fbrmation of homo- or hetero-dimers, leading to the activation of distinct
                                       iv
intracellular pathways, including the mitogen-activated protein kinase (MAPK) and the
phosphatidylinositol-3 kinase (PI3K) pathways, specific inhibitors fbr each pathway were used to
reveal functional signaling transduction. The data indicated that PI3K inhibitor was more
ethcient in suppression of nNRGI -induced spermatogonial proliferation than MAPK inhibitor.
                                                                        'Thus, nNRGI can induce spermatogonial proliferation by direct and indirect action on
spermatogonia vid the ErbB2 and ErbB4 fecept6rs, which leads to the activation of mainly PBK
pathway.
    To funher understand the mechanism underlying activation of the spermatogonial
proliferation by NRGIErbB, proteins interacting with ErbB2 or ErbB4 were screened. Using co-
immunoprecipitation method, coupled with matrix assisted laser desorption-time of fiight-mass
spectrometry (MALDI-TOF-MS) or electron spray ionization (ESD, spliceosome associated
protein 155 (SAP 1551SF3BiS5), a component of the U2 small nuclear ribonucleoprotein, was
detected as a protein interacting with ErbB4 in the testis. Cloning and sequencing revealed a
partial cDNA approximately 2.7-kb in length encoding 930 amino acid residue homologous to
mouse SAPI55. Expression analysis in different spermatogenic stages and cell types showed that
SAP155 was expressed in germ cells at all the spermatogenic stages examined. On the other
hand, co-immunoprecipitation of SAP155 with ErbB4 antibody as well as the reciprocal co-
immunopreciphation demonstrated their interaction only in primary spermatocyte stage,
suggesting that SAP155-ErbB4 binding may be linked to the downregulation of the germ cell
proliferation in primary spermatocyte stage,
V
Figure 1.1
Figure 1.2
Figure l.3
Figure l.4
Figure 1.5
Figure 2.1
Figure 2.2
Figure 2.3
Figure 2.4
Figure 2.5
Figure 2.6
Figure 3.1
Figure 3.2
Figure 3.3
Figure 3.4
Figure 3.5
Figure 3.6
Figure 3.7
Figure 3.8
Figure 3.9
LIST OF FIGURES
Spemiatogenesis in mammals..............................･･e････････-････････････････････････････････
Spermatogenesis in newts...............................................................................･
A ctoss-section ofthe seminiferous tubule.......................................................
Newt testicular structure.......,...........................................................................
Hormonal interactions involved in the regulation ofspermatogenesis............
cDNA cloning ofnlg-NRGI and nCRD-NRGI..............................................
Stage-specific and cell-type specific mRNA expression of nNRGI isofbrms.
Effbct ofFSH on the expression ofnlg-NRGI protein
in different cell types........................................................................................
Effect of nNRGI -EGIT on spermatogonial proliferation
in organ culture oftesticular fragments............................................................
Effect ofnNRGI -EGF on spermatogonial proliferation
in reaggregate culture.......................................................................................
Effect of the nNRGI -EGF antibody on spermatogonial proliferation.. . . . . .. . . . . .
Schematic representation of the fbur ErbB receptor tyrosine kinases. ... .. . .. . .. .
The ErbB signaling network............................................................................
The diffbrential abilities ofEGIF-like growth factors to interact
with distinct ErbB receptor combinations........................................................
Concentiation-dependent effbcts ofErbB inhibitors on NRGI-induced
spermatogonial proliferation in organ culture..................................................
Effects ofErbB inhibitors on nNRGI-induced spermatogonial proliferation
in reaggregate culture.......................................................................................
Dose-dependent effbcts ofPI3K and MAPK inhibitors on
nNRGI -induced spermatogonial proliferation in organ culture. . . . . . . . . . . . . . . . . . . . . .
Effects of PBK and MAPK inhibitors on nNRGI -induced
spermermatogonial proliferation in reaggregate culture..................................
Effects ofthe inhibitors on purified spermatogonia.........................................
Expression ofErbB2 and ErbB4 in diffbrent spermatogenic stages and
cell types.mm.......Hm.".........".-･････････-･･･-･･････････-･-･･･-････-････--･･-･･･-････-･･
vi
3
5
8
10
13
26
28
30
32
34
36
55
57
59
62
63
65
66
68
70
Figure 4.1
Figure 4.2
Figure 4.3
Figure 4.4
Figure 4.5
Figure 4.6
Figure 4.7
Figure 4.8
Figure 4.9
Figure 4.1O
Proteolytic cleavage pathway fbr ErbB4............................................･･････････････
Co･-immunopreciphation with ErbB2 and ErbB4 antibodies
upon FSH or PRL treatment.............................................................･･･････････････e
ErbB2- or ErbB4-precipitated proteins from FSH-treated newt testis.............
MALDI mass spectrum of the peptides obtained from
ErbB4-precipitated protein number 1...............................................................
Identification ofSAP155 as an ErbB4-interacting protein..............................
MSIMS analysis forthe selected peptide.........................................................
Validation ofMS result....................................................................................
The deduced amino acid sequence alignment ofnewt SAPI55
with those ofXenopus, mouse, rat and human................................................
Expression ofSAPI55 in diffk)rent spermatogenic stages and cell types........
Co-immunoprecipitation with ErbB4 and SAP antibodies
in different spemiatogenic stages.....................................................................
84
87
89
91
92
93
94
96
98
1OO
vli
LIST OF TABLES
Table 4.1
Table 4.2
Table 4.3
ErbB2-binding proteins identified by MALDI-TOF analysis.............................
ErbB-4-binding proteins identified by MALDI-TOF and ESI analysis.............
Primers used fbr cDNA cloning..........................................................................
90
90
104
Vlll
Symbols ofamino acids
          A
          B
           C
          D
           E
           F
           G
          H
           I
          K
          L
          M
          N
           P
          Q
          R
           S
           T
          V
          W
          Y
          z
 Symbols ofnucleic acid
          A
          C
          G
          T
          U
LIST OF SYMBOLS
Ala
dsx
Cys
Asp
Glu
Phe
Gly
His
Ile
Lys
Leu
Met
Asn
Pro
Gln
Arg
Ser
Thr
Val
Trp
Tyr
Glx
iX
Alanine
Asparagine or Asparatic acid
Cysteine
Asparatic acid
Glutamic acid
Phenylalanine
Glycine
Histidine
Isoleucine
Lysine
Leucine
Methionine
Asparagine
Proline
Glutamine
Arginine
Serine
Threonine
Valine
Tryptophan
Tyrosine
Glutamine or Glutamic acid
Adenosine
Cytidine
Gaunosine
Thymidine
Uridine
BrdU ,
BSA
cDNA
Cy3
DNA
DTT
ECL
EGilFR
EGTA
GSH
GSSG
HRP
IPTG
L-15
LB
mRNA
NCBI
OVA
PBS
PMSF
PRL
Tris
ABBR}i VIATIONS
      Bromodeoxyuridine
      Bovine serum albumin
      complementary DNA
      indocarbocyanine
      deoxyribonuclease
      Dithiothreitol
      Enhanced chemi luminescence
      Epidermal growth factor receptor
      Ethylene glycol tetraacetic acid
      Glutathione reduced
      Glutathione oxidized
      Horse radish peroxidase
      lsopropyl-P-D-thiogalactoside
      Leibovitz- 1 5
      Luria-Bertrani
      messenger Ribonucleic acid
      National Center fbr Biotechnology infbrmation
      Ovalbumin
      Phosphate buffered saline
      Phenylmethyl sulfonyl fiuoride
      Prolactin
      Tris (hydroxymethyl) aminometharie
          x
CHAPTER l
Gθηθm11力’70伽α∫oη
(]hapter 1
1.1 SPERMATOGENESIS
    Spermatogenesis is an essential process fbr sexual reproduction in development. lt takes
place within several structures ofthe male reproductive system and includes sequential mitotic
divisions and two meiotic divisions. Number of the mitotic divisions is species-specific and
stable (Roosen-Runge, 1969). The entire process can be broken up into several distinct stages,
each corresponding to a particular type of cell: spermatogonium, primary spermatocyte,
secondary spermatocyte, spermatid and sperm.
1.1.1 ,Sipermatogenesis in mammals
    Seminiferous tubules of the testes are the starting point for the spermatogenesis. Diploid
type A spermatogonia divide mitotically to produce diploid intermediate gonial cells which then
produce primary spermatocytes. Each preleptotene primary sperrnatocyte duplicates its DNA and
subsequently undergoes two meiotic divisions to produce haploid spermatids. This division
provides sources of genetic variation, such as random inclusion of either parenta1 chromosomes
or chromosomal crossover, to increase the genetic variability ofthe gametes. Spermatids, which
possess half the normal complement of genetic material, are then developed into spermatozoa,
mature male gametes in many sexually reproducing organisms.
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                     Type A spermatogonia
  [IYpe B . - i,,, e .t. - .."k.i",If!.!il'd """['T', i"' 'l d"`vH'ljl. '"'L ,i,-'t'i.f;:'i./s
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                             '     P"slPi,IIi,S,[,illl/,atigiC,yt,e ,,,efi.Il2}}. ,,.e.",ts'' Cytopiasmicbridges
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Figure 1.1 Spermatogenesis in mammals Different types of germ cells during spermatogenesis are shown.
Cytoplasmic bridges form between differentiating cells facilitating synchrony of the wave of germ cell
development. Adodij}ed.fiom Developmental Biology Sbott jFl Gilbert le(V, SinuaerAssociates, 7'h ed, Flig. 19.20,
p 63O (Bloom and]Ecxwcett, 197Lsp
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1.1.2 Siperntatngenesis in amphibians (7Vewtw
    In newts, testicular function shows marked seasonal changes, as is the case with many
species of amphibians living in temperate climates (Lofts, 1974; Pierantoni, 1998). During the
relative warm period, spermatogenesis occurs within sperrnatocysts which are placed in the
lobules, corresponding to the seminiferous tubules in mammals, and during the relative cool
period, sexual characteristics develop (Tanaka and Iwasawa, 1979; Tanaka and Takikawa, 1984).
Primary spermatogonia proliferate synchronously through 7 mitotic divisions and then
differentiate into primary sperrnatocytes in the 8th generation. in newt testis, mitosis of
spermatogonia and meiosis of spermatdcytes start from spring to early autumn. Transfbrmation
of spermatocytes to spermatids occurs in the end of summer; accordingly, a large number of
spermatids can be observed in autumn. After morphogenetic processes of spermatids, mature
male gametes, spermatozoa, are developed in late autumn.
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Figure 1.2 Spermatogenesis in newts A) After several round ofmitosis, sperrnatogonia differentiate into primary
sperrnatocytes that undergo two meiotic divisions, giving rise to roimd spermtatids that eventually diflferentiate
into mature sperm. B) After the 7th mitotic division, spermatogonia initiate meiosis in the 8th gerieration and
differentiate into preleptotene spermatocytes ooodij7ed.from Yazawa et aL, 2000cO.
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1.2 STRUCTURAL and FUNCTIONAL RELATIONSHll?S of SOMATIC and GERM
CELLS
    The mammalian testis consists of two compartments: the interstitium and the seminiferous
tubules. The composition of the interstitium difliers among species, but in general it contains
Leydig cells, macrophages, endothelial cells, lymph space and blood vessels (Fawcett, 1973).
The seminiferous tubules are avascular and contain different types of germ cells embedded in
Sertoli cells (de Kretser and Kerr, 1988). Peritubular myoid cells and a basal lamina are located
between two compartments and surrounding the seminiferous tubules.
    The function of the interstitial Leydig cells is the production and secretion of androgens.
Lutemizing hormone (LH) is the main regulator ofLeydig cell function, but the cells also take
part in a complicated interplay between different cell types in the testis. Factors secreted by
Sertoli cells have been reported to affect Leydig cell mitosis, the number ofLH, gonadotropin
releasing hormone (GnRH) receptors and LH-stimulated testosterone secretion in viro (Kerr and
Sharpe, 1985). Peritubular myoid cells are in close contact with the Leydig cells in interstitium
(Skinner et al., 1991) and together with the Sertoli cells they produce an extracellular matrix to
provide structural support fbr the spermatogenic epithelium (Skinner et al., 1985). Peritubular
myoid cells produce a potential regulator of Sertoli cell function, termed PmodS (Reritubular
myoid cell factor which modulates Sertoli cell function; Skinner and Fritz, 1985; 1986). in cell
cultures, this paracrine factor has a marked impact on a number of Sertoli cell functions: it
increases the production of androgen binding protein (Tung and Fritz, 1980; Hudson and Stocco,
1981) and transfenin (Holmes et al., 1984; Skinner and Fritz, 1985). Sertoli cells are the only
somatic cell type of the spermatogenic epithelium. They form functional blood-testis barriers
consisting oftightjunctions located in between neighbouring Sertoli cells (Sharpe, 1983; Saez et
al., 1987; Bardin et al., 1988). The conuibution of Sertoli cells to these barders is important
because junctional contacts between adjacent Sertoli cells restrict the passage of many growth
factors, nutrients and hormones from the basal to the adluminal compartment of the seminiferous
tubule. Germ cell development takes place in the protected environment of the seminiferous
tubules, as a defined series ofdevelopmenta1 events (Clermont and Harvey, 1967).
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Spermatogenesis does not seem to rely on direct dontrol of the germ cells by the endocrine
system, but rather is dependent on.hormone action on Sertoli cells and cell-cell interactions
between germ cells and Sertoli cells (Griswold et al., 1988; Skinner, 1991). In this respect,
Sertoli cells are also referred to as nursing and supporting cells of the germinal epithelium. For
example, Sertoli cells provide an energy-yielding substrate fbr the developing germ cells in the
form of lactate (Jutte et al., 1983), which play an important role in detoxification of
antisperrnatogenic compounds (Grootegoed J.A., et al., 1989). The most important hormonal
regulator of spermatogenesis, FSH, exerts its actions by regulating activities of Sertoli cells
directly, because this is the only oell type in males that expresses the FSH receptor (Heckert and
Griswold et al., 1991). Androgen action is involved in effects not only on the Sertoli cells but
also on the androgen receptor expressing peritubular myoid cells (Ruizeveld de winter et al.,
1991). Direct action of androgens on germ cells is not very likely, because these cells do not
express androgen receptors (Anthony et al., 1989)
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     Newt testis consists ofthe lobules which is ensheathed by basement membranes. Clonally
derived germ cells are enclosed in a cyst, the smallest unit ofthe testis, and surrounded by Sertoli
cells within the lobules. Leydig-like cells, also called pericystic cells or lobule boundary cells,
blood vessels and red blood cells are located outside the lobules. The testis displays well-marked
zones of spermatogenic cell types because the lobules formed at the cephalic region gradually
acquire more caudal positions as the cells mature (Callard et al., 1978). All spermatogenic stages
from spermatogonia to the most advanced stage can be observed in longitudinal sections, which
permit to isolate germ cells in specific stages ofspermatogenesis.
    The functions of pericystic and Sertoli cells are not well known in newt testis. A5-3P-
hydroxysteroid dehydrogenase (3P-HSD) reaction is detected strongly in pericystic cells in
glandular tissue, but barely in germ cells or Sertoli cells (Imai and Tanaka 1978). Sertoli cells
proliferate along with the proliferation of spermatogonia and they are degenerated after
spermiation (Abe, 2004). In each cyst, germ cells, which are in the same stage of diflierentiation,
rnake a close contact with Sertoli cells. The blood-testis banier, formed by Sertoli cells, shows
size selectivity in newt testis. It allows small molecules (--500 Da) to penetrate into the cyst, but
not larger ones (>1.9 kDa) (Jin et al., 2008). Binding experiments for fractionated germ and
somatic cells indicated that FSH binds to somatic cells (mostly Sertoli cells) but not to gerrn cells
(Ji et al., 1995). Funhermore, a cDNA encoding a FSH receptor (FSH-R) is isolated from the
Sertoli cells (Nakayama et al., 2000) and FSH-activated Sertoli cells are shown to mediate
proliferation of spermatogonia and their differentiation into primary spemiatocytes (Abe and Ji,
1994; Abe, 2004).
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Figure 1.4 Newt testicular structure A) Newt testis consists ofseveral zones each consisting ofthe same stage of
spermatogenesis; sperrnatogonial stage (SG), primary spermatocyte stage (PC), round spermatid (RT) and elongated
sperrnatid stage (ET), B) A cyst, smallest unit of the testis, consists of a germ cell clone derived from a single
sperrnatogonium, and Sertoli cells. Cysts are packed in a lobule that is surrounded by basement membrane. Some
Leydig-1ike cells, called pericystic cells, are placed outside the lobules (Abe, 2004).
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1.3 HORMONAL REGULATION of SPERMATOGENESIS
    Hormonal control ofspermatogenesis varies among species. in most species, however, it is
initiated by the interaction of the hypothalamus, pituitary gland and testicular somatic cells at
puberty. The gonadotropins, luteinizing hormone (LH) and fbllicle stimulating homione (FSH)
are secreted by the pituitary gland which is stimulated by the gonadotropin releasing hormone
(GnRH) from the hypothalamus.
    In mammals, LH acts upon Leydig cell and it is responsible fbr the production of
testosterone, the male hormone that exerts both endocrine activity and intratesticular activity
such as spermatogenesis. FSH stimulates both the production of androgen binding protein by
Sertoli cells and the fbrmation ofthe blood-testis banier. Androgen binding protein is essential
fbr concentrating testosterone in levels high enough to initiate and maintain spermatogenesis.
Therefbre, Sertoli cells themselves mediate parts of spermatogenesis through hormone
production. They are a!so capable of producing inhibin hormone, which inhibits pimitary
gonadotropin production, preferentially that of FSH (Burger and Igarashi, 1988) and thus it is
considered to be a part ofthe pituitarylgonad feedback mechanism.
    ln amphibians, development of the gonads is affected by the ambient temperature (Tanaka
and Takikawa, 1984; Rastogi et al., 1987). Comparison of the biological propenies of newt
gonadotropins showed FSH is excreted by the pituitary only in July, while the activity ofFSH
                     'and LH is very similar in February (Tanaka and Takikawa, 1984). In newts, presence of both
                'FSH and LH in pituitary was demonstrated by isolation of newt FSHB and LH6 cDNAs (Saito et
al., 2002) but there has been no report on the biological action of newt LH and FSH, because
these proteins in purified fbrm are not available (Kano et. al., 2005). Bullfrog LH stimulates
testosterone production and spermiation, while bullfrog FSH maintains testicular weight and
stimulates spermatogenesis (Tanaka et al., 2004). Ovine FSH also promotes spermatogenesis,
while LH has poteney in testosterone production in newt testis (Tanaka and Takikawa, 1984).
Secretion of estrogen is primarily stimulated by ovine FSH (Callard et al., 1978; Bolaffi and
Callard, 1981) but the role of estrogen in newt sperrnatogenesis has not been clarified yet. Direct
evidence is fbund fbr gonadal negative feedback control ofplasma gonadotropins in amphibians
11
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by using iadioimmunoassay (McCreery and Lichg 1984; Pavgi and Licht, 1989). ln newt testis,
gonadoectomy increased the expression levels of LHP and FSHB, and testosterone replacement
inhibited the expression ofLHP, but not FSHP, indicating that FSHP expression is regulated by a
non-steroid factor (Kano et al., 2005). The negative feedback system by andfogen, namely
testosterone is weakly regulated in newts (Kano et al., 2005).
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1.4 OBJECTIVES OF THE 1llESIS
    In adult organism, reproduction is one of the most intriguing aspects of development.
Spermatogenesis produces mature male gametes, which are able to fenilize the 'counterpart
female gamete to produce a single-celled individual known as a zygote. This is a cornerstone of
sexual reproduction and involves two gametes each contributing half the normal set of
chromosomes (haploid) to result in a chrornosomally normal (diploid) zygote. The abnormalities
during the process cause male infenility or abnormal zygotes which would not survive fbr long
time after conception. The cooperation with several hormones and the factors locally secreted
from gonadal somatic cells are now generally accepted to play a crucial role in regulating
spermatogenesis. The mechanisms behind this phenomenon are the great interest to understand
the treatments arid cures for male infenility or to provide targets for contraceptive development.
    The first aim ofthe current study was to identify the local factor expressed highly upon FSH
treatment in newt testis. The second aim was to investigate experimentally the role ofthe factor
on the spermatogonial proliferation and the last one was to study the signaling mechanism ofthe
factor in newt spermatogenesis.
    ln the general introduction of this dissertation (Chapter 1) an overview is given about the
process of the spermatogenesis, including stages and location in both marmials and urodels.
Attention is then focused on the role of somatic cells and the factors that infiuence gamete
development. This overview is completed with a description of the hormonal regulation of
spermatogenesls.
    The fbllowing chapter fbcuses on the isolation of the factor locally expressed in testicular
cells in response to FSH treatment. Emphasis is put on the expression and the role ofthe factor in
spermatogonial proliferation using diflierent culture systems (Chapter 2).
    In chapter 3, the dissertation is concerned with the receptors of the factor, which play a role
during spermatogenesis. Specific inhibitors fbr each receptor were used in diflierent culture
systems to explore the functional receptors in spermatogonial proliferation. The expression
pattern ofthe receptors is presented in diflierent spermatogenic stages and cell types.
14
C7laapter 1
    Since ligand-induced phosphorylation ofthe receptors serve as docking sites for a variety of
signaling molecules whose recruitment stimulates numerous intracellular signaling cascades, the
proteins interacting with the receptors were analyzed by immunoprecipitation coupled with
matrix assisted laser desorption-time of flight-mass spectrometry (MALDI-TOF-MS) or electron
spray ionization (ESD in chapter4.
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2.1 INTRODUCTION
    Spemiatogenesis is an essential process fbr sexual reproduction in development. It is
uiggered by the sequential mitotic divisions of spermatogonia, fbllowed by their diffbrentiation
into spermatocytes. After two meiotic divisions, spermatocytes develop into spemiatids, which
possess halfthe norrnal complement ofgenetic material, and then into spermatozoa, mature male
gametes in many sexually reproducing organisms. This complex process is controlled by
cooperation with several hormones and testicular somatic cells. Follicle-stimulating hormone
(FSH) is one of the most important homiones required for early gonadal development, maturity
and function (Sairam and Krishnamunhy, 2001). It is secreted by the pituitary gland and act on
testicular somatic cells (Means et al., 1980; Ritzen et al., 1981; Hodgson et al., 1983; (lriswold et
al., 1988), mainly Sertoli cells, through the specific receptor. Sertoli cells have essential roles in
the regulation of spermatogenesis. They not only represent the only cellular component of the
blood-testis banier but also produce and secrete local factors to germ cells (Dym et. al., 1997).
    In mammalian testis, Sertoli cells have been shown to synthesize stem cell factor (SCF)
(Motro et al., 1991; Tajima et al., 1991), which plays a pivotal role in survival (Packer et al.,
1995; Yan et al., 2000), proliferation and differentiation (Yoshinaga et al., 1991; Sette et al.,
2000) of germ cells expressing the receptor c-kit (Manova et al., 1990; Sorrentino et al., 1991).
insulin-like growth factor-I aGF-I) is another factor shown to act specifically on spermatogonia
and primary spermatocytes ofrainbow trout (Loir and Le Gac, 1994). The mRNAs fbr IGIT-I and
its receptors are present to a greater extent in Sertoli cell-enriched populations and in those
containing spermatogonia and primary spermatocytes (Le Gac et al., 1996). These findings may
define SCF and IGF-I as paracrine factors derived from Sertoli cells in the regulation of
spermatogenesls.
    in newt testis, FSH alone is suflicient to stimulate spermatogonial proliferation and
differentiation into primary spermatocytes through the receptor expressed on Sertoli cells in both
organ and reaggregate cultures (Abe and Ji, 1994; Abe, 2004), but not in the culture of
spermatogonia alone ato and Abe, 1999). In addition, SCF and IGF-I, both of which are
upregulated in response to FSH (unpublished; Yamamoto et al., 2001), induce spermatogonial
22
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proliferation (Abe et al., 2002) and differentiation (]Nakayama et al., 1999), respectively, in the
organ culture. Recently, it was demonstrated that the blood-testis barrier fbrrned by Sertoli cells
shows size selectivity, which allows small molecules (-500 Da) to penetrate into the cyst, but not
larger ones (>1.9 kDa) (Jin et al., 2008). Therefore, SCF and IGF-I induce spermatogonial
proliferation and differentiation indirectly in organ culture. Though it is thus considered that the
FSH effects are necessary to be mediated by local paracrine factors, which are secreted from
Sertoli cells and act directly on spermatogonia within the testis, such factors have not been
identified yet.
    Because of the complex anatomical organization of the germinal compartment in
mammalian testis (the Sertoli cells are normally associated with fbur or five gerrn cell
generations), it is difllcult to examine the stage-specific effects of the regulatory factors in the
organ culture (Yamamoto et al., 2001). in contrasg clonally derived germ cells are enclosed in a
cysg the smallest unit of the testis, and surrounded by Sertoli cells within the lobules in newt
testis (Callard 1991; Abe, 2004). Therefbre, newt testis is an apprppriate model to isolate germ
cells at a specific stage and study the efli2ct of various factors on specific stage of
spermatogenesls.
    To identify FSH-upregulated local factors exerted directly in spermatogonial proliferation
and differentiation, an EST (Expression Sequence Tag) library containing 5321 clones was
prepared from newt testes and differentially screened by microarray analysis. Neuregulin 1,
termed as newt neuregulin 1 (nNRGI), was identified as one of the novel FSH-upregulated
clones. First, partial cDNAs encoding two different clones (newt immunoglobulin (nfg)-type and
newt cysteine-rich domain (nCRD)-type) were isolated and then their expressions were
examined in spemiatogenic stages and testicular cell types by semi-quantitative and quanthative
RT-PCR. Next, the effect of nNRGI on sperrnatogonial proliferation was tested with
recombinant epidermal growth factor (EGF)-like domain of nNRGI (nNRGI-EGF) in organ
culture and reaggregated culture with or without somatic cells. The data indicate that nNRGI
plays a pivotal role in promoting spermatogonial proliferation by acting both directly and
indirectly via somatic cells on spermatogonia in newt testis.
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2.2 RESULTS
  2.2.1. diArA cloning and structitre ofnlVRGI isojTorms
         '       '
    To screen out FSH-upregulated genes, microarray analyses was perfbrmed from a cDNA
library including 5321 independent clones isolated from newt testis containing spermatogonial
and early primary spermatocyte stages, and these clones were hybridized with cDNA synthesized
from tota1 RNA extracted from testes 48 h after FSH or vehicle injection. NRGI was identified
as one of the 61 FSH-responsive cDNA clones. Nucleotide sequencing revealed that the clone
contained an approximately 637 bp cDNA with 74% idemity to inouse NRGI belonging to
members of the NRG family conserved among mammals (Falls, 2003) and amphibians (Yang et
al., 1998, 1999). Therefbre we referred to the clone as newt NRGI (nNRGI). RT-PCR analysis
confirmed that the mRNA expression of NRGI gene was induced by FSH at the spermatogonial
stages ofnewt testis (data not shown).
    As the single NRGI gene produces many isofbrms (Burden and Yarden 1997; Buonanno
and Fischbach, 2001; Falls, 2003), we aimed to isolate cDNAs encoding nNRGI clones in newt
testis. PCR was perfbrmed with primers based on the sequences in the extracellular domain of
Xlanopus laevis Ig-type and CRD-type NRGI. Using newt testes cDNA as a template, two
different clones ofapproximately 500 bp were obtained.
    Cloning and sequence analysis of the clones revealed that the first clone was 483 bp in
length and the deduced amino acid sequences showed the presence of several domains such as
the Ig domain and EGF-like domain that have been characterized in NRGI Ig-type isoform of
.Il7nopus laevis (Fig. 2.1 A) (Yang et al., 1998). Amino acid sequence comparison ofthis clone
showed -75% identity to X2,nopus laevis Ig-NRGI, -57% identity to human and 44･-48%
identities to mouse, chick and rat counterparts. Therefbre this clone was referred as newt Ig-
NRGI (nfg-NRGI) isoforrn. The domains in Ig-like molecules are grouped into fbur types:
variable (V-type), constant-1 (C-1 type), constant-2 (C-2 type) and intemiediate a-type) (Smith
and Xue, 1997). The spacing ofthe cysteine residues ofnlg-NRGI fits the consensus fbr an Ig-
like domain ofC2 type (Yang et al., 1998). The EGF-like domain is well defined with its six
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cysteine residues which form three disulfide bonds. Two types ofEGF-like domains have been
identified, ct and S, which differ in the amino acid sequences between the 5th and 6th cysteine and
in the region carboxyl-temiinal to the 6th cysteine (Holmes et al., 1992). In nlg-NRGI, the EGF-
like domain was a S subtype and identical to the X;2nopus laevis P2 type EGF-like domain. A
spacer domain wnhout any amino acid insenions, namely SPO (Yang et al., 1998), was between
Ig-like and EGF--like domains and two potential N-linked glycosylation sites were just upstream
from the spacer domain (Fig. 2.1A).
    The second clone was 696 bp in length and the deduced amino acid sequence revealed the
presence ofa cysteine-rich domain at the N-terminal region that has been characterized in NRGI
CRD-type isofbrm of.henopus laevis (Fig. 2.IB) (Yang et al., 1999). This clone showed "-94%
identity in amino acid sequence to .XZenopus laevis CRD-NRGI and only 49-53% identity to
those of human (49%), mouse (50%), rat (50%), and chick (53%). Therefore this clone was
referred as newt CRD-NRGI (nCRD-NRGI) isofbrm. The cysteine-rich domain was highly
conserved among human, rat, and chick with over 809t6 amino acid identity. The P2 type EGF-
like domain was identical with that of nfg-NRGI. The spacer domain between the CRD and
EGF-like domain had 43 amino acid insenions, namely SP43 (Yang et al., 1999), of which
amino acid sequence was identical to .8Z7nopus one but distinct from those ofother species and it
was rich in serine and threonine residues, which are potential sites for O-linked glycosylation.
Potential N-glycosylation sites were absent (Fig. 2.1B).
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Figure 2.1cDNA cloning of nlg-)IRGI and nCIll)-NRGI The deduced amino acid sequences ofnewt Ig-NRGI
(A) ･ and CRD -NRGI(B) were aligned with those oflYbnopus laevis, chicken, mouse, rat and human. The respective
amino acid nurnbers are shown at the both sides.Ide tical amino ac  residues among all species are indicated by
asterisks. The Ig-1ike domain and CRD are underlined.The EGF-1ike domains are sh wn by dashed 1ines. Cysteine
                                                                                'residues within the EGF-1ike domains and potential N-glycosylation sites are indicated by single and double dots,
respectively.The amino acid sequence used for the production of nlg-NRGIantibody is overlined.Spacer omain
with (B) or without (A) 43 amino acid insertions is shown by a box.
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2.2.2 mRZVA exipression ofnlVR61 isqfornis in newt testis
    To determine mRNA expression of nlg-NRGI and nCRD-NRGI during spermatogenesis,
semi-quantitative and quanthative RT-PCR was perfbrmed using the total RNA derived from
cysts at various spermatogenic stages, rich in early (3rd - 4th) spermatogonia, late (6th - 7th)
spermatogonia and primary spemiatocytes <Fig. 2.2 A and B). mRNA expressions of botli nlg-
NRGI and nCRD-NRGI were highly detected at spermatogonial stages than that'ofprimary
sperrnatocyte stage. Noticeably, nlg-NRGI expression was remarkably high in the late
sperrnatogonial stage.
    To examine the effect ofFSH on the mRNA expression of two isofbrrns in different cell
types, the fractionated testicular cells were treated wnh FSH and then RT-PCR analyses were
perfbrmed (Fig. 2.2 C and D). nCRD-NRGI mRNA was constitutively expressed both in
spermatogonial and somatic ce11 fractions and its expression level was barely affected by FSH.
On the other hand, nfg-NRGI mRNA was expressed predominantly in somatic cell fraction and
the expression level was remarkably higher in FSH-treated somatic cells than those of non-
treated one (Fig. 2.2 C and D). This result indicates that FSH increases nfg-NRGI mRNA
expression in somatic cells.
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Figure 2.2 Stage-specific and cell type-specific mRINA expression ofnNRGI isoforms (A and B) Stage-specific
mRNA expression of nNRGI isofbrrns. mRNA was isolated from cysts with 3'd -4th generation of early
spermatogonial (EG), the 6th-7th generation of1ate sperrnatogonial (LG) and the priniary spermatocyte (PC) stage in
10 "im frozen sections dissected from newt testicular fragments by P.A.L.M. A) Semi-quanthative RT-PCR was
perfbrmed at 45 cycles for nNRGI isofbrms and 25 cycles for newt elongation factor-la (nEF-1ct) as an internal
control. M: 1OO bp DNA ladder. B) The expression of each isofbrm was quantified by real-time quantitative PCR
(Q-PCR). Relative expression of the target genes (2-""Ct ) obtained from 3 independent experirrients was analyzed by
the Student t test (*p<O.Ol). (C and D) Cell-type specific and FSH-dependerit mRNA expression of nNRGI
isoforms. Somatic and germ cells fractionated and then treated with (+) or without (-) FSH (2oo nglml) in L-15
medium tbr 24 hours at 250C and theri mRNA was isolated fbr PCR analysis. C) Semi-quantitative RT-PCR was
per fbrmed as in (A). D) The expression of each isoform was quantified by Q-PCR.
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2.2.3 Efact ofEgH on the expression ofnlgeNRGI protein in dltjfbrent cell impes
    To demonstrate the expression of nlg-NRGI protein in different cell types, we used an
antibody produced against nlg-NRGI peptide (Fig.2.IA, overlined). Specificity of the antibody
                                  'was examined by immunoblotting of ovalbumin-coajugated nlg-NRGI (nig-NRGI-OVA) and
                        'nCRD-NRGI (nCRD-NRGI-OVA) peptides synthesized from amino acid residues 42-60 and
72-84, respectively. The nlg-NRGI-OVA peptide was detected using nlg-NRGI antibody,
whereas nCRD-NRGI-OVA was not detected (Fig. 2.3 A). The expression of the nlg-NRGI
protein was demonstrated in somatic cells and the expression was increased by in vitro FSH
treatment (Fig. 2.3 B). Preincubation ofthe antibody with the antigen peptide blocked the signals
(Fig. 2.3 A, B lower panel)
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Figure 2.3 Effect of FSH on the expression of nlg-NRGI protein in different cell types A) OVA-coajugated
nlg-NRGI and nCRD-NRGI (10 pg of each) were immunoblotted wnh an antibody against nlg-NRGI in the
absence (upper panel) and presence (lower panel) of the antigen peptide (250 pg). OVA-coajugated nCRD-NRGI
was used as a negative control. B) Fractionated somatic and germ ce11s were incubated with (+) or wnhout (-) FSH
(200 ng/ml) in L-15 medium for 24 hours at 250C and 10 pg of each cell lysates were immunoblotted with the nlg-
NRGI antibody in the absence (upper panel) and presence (lower panel) ofnlg-NRGI peptide (250 pg).
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2.2.4 Etfect ofrecombinant nlVRGI on sperntatagonialprolijleration in organ culture
    Since the EGF-like domain ofNRGI is alone sufficient fbr binding and activaimg receptors
to induce cellular responses (Holmes et al., 1992; Wen et al., 1994), various concentrations of
recombinant EGF-like domain of nNRGI (nNRGI-EGF) were added to culture system to
determine the role of nNRGI in spermatogonial proliferation. In organ culture, testicular
fragments were cultured for 1 week and the proliferative activity of spemiatogonia was
determined (Fig 2.4). Addition of nNRGI-EGF increased the number of BrdU-positive germ
cells in a concentration-dependent manner up to 350 nM, whereas 700 nM did not show any
significant difference compared to 350 nM. This result indicates that nNRGI promotes
spermatogonial proliferation indirectly through somatic cells, because nNRGI-E(IF could not
have worked on germ cells directly due to size-selective barrier formed by Sertoli cells that
enclose germ cells in a cyst (Jin et al., 2008).
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Figure 2A Effiect of nNRGI-EGF on spermatogonial proliferation in organ culture oftesticular fragrnents
Testicular fragments were cultured for 1 week at 180C in the medium containing none (control) or various
conceritrations ofnNRGI-EGF. Results are presented as mean ± SEM ofthe percentage ofBrdU-positive cysts from
3 independerit experirnents. The value ofthe control was taken as 1 .0. *P<O.05
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2.2.5 Illffact ofrecombinant nlVRGI on spermatngonialprolijZiration in reaggregate culture
    Hence, to expose germ cells to nNRGI-EGF directly, reaggregate cultures, in which size-
selective barrier was destroyed by dissociation oftestis with collagenase treatment (Ito and Abe,
1999; Jin et al., 2008) was perfbrmed (Fig. 2.5A). After one week, both nNRGI-EGF and FSH
stimulated spermatogonial proliferation to larger extent than in controls, indicating that nNRGI-
EGF can promote spermatogonial proliferation directly andlor through activation of somatic cells
(Fig. 2.5B).
    To reveal whether nNRGI-EGF acts on spermatogonia directly or indirectly via somatic
cells, it was added in reaggregated culture ofpurified spermatogonia (Fig. 2.5C). FSH had little
effect on promoting spemiatogonial proliferation, verifying that percentage of the contaminated
Sertoli cells was very low. On the other hand, nNRGI-EGF remarkably stimulated
spermatogonial proliferation (Fig. 2.5D). Thus nNRGI-EGF was demonstrated to stimulate
spermatogonial proliferation directly.
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Figure 2.5 Effect of nNRGI-EGF on spermatogonial proliferation in reaggregate culture A) Reaggregates
formed within collagen matrix consisting of both germ and somatic cells. Somatic cells, characterized with their
ellipsoidal or crescent-shaped nucleus, and germ cells, recognized with their round or oval-shaped nucleus with
some heterochromatin granules, are indicated by arrows and arrowheads, respectively. B) Effect ofnNRGI-EGF on
sq?errnatogonial proliferation. Reaggregates (A) were cultured for 1 week at 180C in the medium containing none
(control), FSH (200 nghn1), or nNRGI-EGF (350 nM) and the percentage ofBrdU-positive cells was shown as
mean ± SEM from 3 independent experiments. The value of the control was taken as 1.0. C) Reaggregates
consisting of purified spermatogonia (no Sertoli cells per 1000 spermatogonia were observed). D) Effect of
nNRGI-EGF on spermatogonial proliferation. Reaggregates (C) were cultured as in (B). *P<0.01; *"P<O.05
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2.2.6 E17Z,ct of nNRGIantibody on the sperinajogonialprolij7!ration induced bj7 nNRGI and
EgH
    FSH induces newt spermatogonial proliferation and their differentiation through its
receptor expressed on Sertoli cells (Abe, 2004). ln order to examine whether FSH promotes
sperrnatogonial proliferation by activating Sertoli cells to produce nNRGI, antibody against
EGF-like domain of nNRGI (anti-nNRGI-EGF) was added to the reaggregated culture of
testicular cells. The specificity of the antibody was first examined by immunoblotting and shown
that it reacted with nNRGI-EGF protein but not with un-related protein (nSCF) (Fig. 2.6A).
Preincubation ofthe reaggregates with the antibody prevented the stimulatory effect ofnNRGI-
EGF on spermatogonial proliferation, while normal mouse IgG did not show any significant
effect, verifying that the antibody specifically inhibits the action of nNRGI-EGF. ln addition, the
antibody also inhibited the spermatogonial proliferative activity stimulated by FSH, whereas it
did not suppress the activity in the absence ofFSH (Fig. 2.6B). These resuks demonstrate that
FSH promotes spermatogonial proliferation by activating Sertoli cells to produce nNRGI, at
least partly.
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Figure 2.6 Effbct ofthe nlYRGI-EGF antibody on the spemiatogonial proliferation A) 20 pl of affrmity purified
nNRGI-EGF .and unrelated (nSCF) poly(histidine) fUsion proteins were immunoblotted with anti-His-tag antibody
(left panel) or nNRGI-EGF antibody in the absence (middle panel) and presence (right panel) of 400 pg antigen
(nNRGI-EGF). B) Reaggregates consisting of somatic and germ cells were cultured fbr 1 week at 180C in the
medium containing none (control), FSH (2oo ngfml),'or nNRG1 -EGF (350 nrvD with (+) or without (-) nNRG1 -EGF
antibody (2.5 pg/ml) or normal mouse IgG (2.5 pgfml). Effect of the antibody on the spermatogonial proliferation
was represented as mean ± SEM of the percentage of BrdU-positive gerrn cell number obtained from 3 independent
experiments. The value of the control was taken as 1 .0. *p<O.05
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2.3 DISCUSSION
    in newt testis, FSH induces spermatogonial proliferation and their differentiation by binding
its receptor expressed on Sertoli ce11s (Abe, 2004). We identified newt onhologue of NRGI as
one ofthe downstream genes using an EST library whose expressions were upregulated by FSH
with microarray analyses. NRG belongs to EGF family which is highly conserved among
vertebrates (Falls, 2003; Harris et al., 2003). EGF family proteins play an important role not
only in proliferation and differentiation of somatic cells during development, but also in those of
germ cells during gametogenesis in many species (Gilboa and Lehmann, 2004; Shilo, 2006). The
present results show: (1) cDNAs for two types of nNRGI, nfg-type and nCRD-type, were
isolated; (2) mRNA fbr both types ofnNRGI is expressed in spermatogonial stage, but scarcely
in primary spermatocyte stage; (3) mRNA fbr nlg-NRGI is highly expressed in somatic cells,
very probably Sertoli cells, and the expression is upregulated by FSH, while that fbr CRD-type is
expressed both in somatic and germ cells and is barely dependent on FSH; and (4) nNRGI
stimulates the proliferation of spermatogonia in organ and reaggregate cultures with somatic
cells as well as in cultures containing purified spermatogonia. These data suggest that nNRGI
functions as an autocrine factor indirectly via Sertoli cells in a FSH-dependent manner and as a
paracrine factor directly, resulting in promoting spermatogonial proliferation in newt testis.
    cDNA cloning by RT-PCR detected two clones potentially encoding the amino acid
sequences highly homologous to the extracellular domains ofX: laevis Ig-type and CRD-type
NRGI which are different in their N-terminal region ag-domain and CRD, respectively) but the
same in their EGF-like domain (B-type). The single NRGI gene is well known to produce
various isofbmis generated by alternative splicing in mouse, chick and frog (Yang et al., 1998;
Buonanno and Fischbach, 2001 ; Falls, 2003). To date about 12 distinct isofbrms have been
reported in X laevis based on the N-terminal region, the spacer domain, and the type ofEGF-like
domain (Yang et al., 1998, 1999). Therefbre, our two clones are suggested to be isofbrrns, nig-
NRGI and nCRD-NRGI, produced from the single gene by altemative splicing. Comparison of
the spacer domain arid EGF-like domain ofour clones to theX laevis isofbrms indicated that our
first clone is Ig-NRGI SPO P2 (Yang et al., 1998) and the second one is CRD-NRGI SP43 P2
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(Yang et al., 1999) in newt. P-type EGF-like domain, which is 10-100 times more potent in
biological activity than ct-type in most assays (Falls, 2003), is prevalent in the nervous system,
whereas ct-type is found in mesenchyme (Meyer and Birchmeier., 1994). interestingly, since P2
type EGF-like domain is shared in both nlg- and nCRD-NRGI and it is well known to bind and
activate receptors and induce cellular responses (Holmes et al., 1992; Wen et al., 1994),
suggesting that EGF-like domain is important fbr signaling and hence, both isoforrns probably
play a pivotal role in spermatogonial proliferation and differentiation. However, differential
expression oftwo isofbrrns in cell types and FSH-dependence of their expression may suggest an
important role for the Ig-domain and CRD in determining the cell types where the isoform acts
on. That may be why two isofbrrns exist potenha11y in newt testis. lndeed, previous studies using
targeted mutations (Wang et al., 2001; Falls, 2003) showed that CRD-type (type M) and Ig-type
(type D NRGI have diflierent cell biological propenies in vivo: Ig-NRGI"' mice die at ElO.5 and
show defects in cardiac, cranial sensory neuronal and sympathetic development (Kramer et al.,
1996; Meyer et al., 1997 ; Britsch et al., 1998), but normal development of Schwann cell
precursors Ovleyer et al., 1997). On the other hand, CRD･-NRGI'i- mice die at binh because ofthe
defects in neuromuscular synapses and unlike Ig-NRGI'i-, they have norrnal heart development
but show degeneration of peripheral and cranial nerves (Wolpowitz et al., 2000). In addition,
another study demonstrates that two isoforms, which are different only in their N-terminal (Ig
and CRD) sequence, undergo distinct proteolytic processing (Wang et al., 2001): Ig-NRGI is
synthesized as a transmembrane proprotein which is proteolytically cleaved to produce a soluble
N-temiinal fragment containing the bioactive EGF-like domain, whereas CRD-NRGI remains as
a transmembrane protein even after cleavage by proteases. Thus, in contrast to CRD-NRGI that
may act as a cell surface signaling molecule (a juxtacrine factor), Ig-NRGI may act as a secreted
molecule (a paracrine factor) (Wang et al., 2001). At neuromuscular synapses motor neuron-
derived Ig-NRGI has been a leading candidate fbr the signal that activates acetylcholine receptor
synapse-specific transcription (Rimer, 2003), while neuronal-derived CRD-NRGI is a critical
primary signals fbr survival fbr terminal Schwann cells (Wolpowitz et al., 2000). These findings
suggest that nlg-NRGI is specialized fbr FSH-dependent paracrine signaling, whereas nCRD-
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NRGI is specialized fbrjuxtacrine (direot-contact) signaling fbr cell-cell communication in newt
testis.
    To determine the function of nNRGI on spermatogonial proliferation in newt testis, we
examined the effect of the recombinant EGF-like domain of nNRGI (nNRGI-EGF) in various
culture systems, because it was reported that the EGF-like domain is alone sufficient for binding
to receptors and induces cellular responses (Holmes et al., 1992; Wen et al., 1994). The results
obtained from the organ culture oftesticular fragment showed that nNRGI-EGIF enhanced the
proliferation of spermatogonia by acting indirectly on them, because macromolecules such as
nNRGI-EGF do not penetrate into testicular cysts (Jin et al., 2008), suggesting nNRGI could
function as an autocrine factor. Therefbre, nNRGI may stimulate the production of other growth
factor(s) that activate spermatogonial proliferation in somatic cells. One candidate fbr the growth
factor is SCF, because we fbund that it is expressed in newt testis (Abe et al., in preparation).
Reaggregated cultures of spermatogonia with somatic cells, where the banier of Sertoli cells is
destroyed, could oircumvent the drawback in organ cultures mentioned above. ln this system,
nNRGI as well as FSH did stimulate spermatogonial proliferation, suggesting that nNRGI
activates spemiatogonia directly andlor indirectly through somatic cells. The addition ofnNRGI
to reaggregated cultures of purified spermatogonia directly stimulated their proliferation,
suggesting that nNRGI could function as a paracrine factor. These indirect and direct actions of
nNRGI on newt spermatogonia are consistent with reports in mammals. In rat testis, the
receptors fbr NRGI, ErbB-3 and ErbB-4, are predominantly expressed in Sertoli cells and
recombinant humati NRGI-ct and NRGI-S stimulate the production oftransferrin and androgen-
binding protein by Sertoli cells (Hoeben et al., 1999). Recently, NRGI is identified as a factor
required fbr the fbrmation of rat type A-aligned (Aal) spermatogonia up to the 32-cell stage in a
glial cell line-derived neurotrophic factor (GDNF)-dependent manner in culture system (Hamra
et al., 2007). in addition to this, NRGI receptors are shown to be also expressed in the
spermatogonia, suggesting that NRGIs do have the potential to directly stimulate the
proliferation of undifferentiated spermatogonia by binding to their receptors (Hamra et al.,
2007). ln newt testis, ErbB4 and other ErbB family receptor ErbB2, known to fbrm hetero-dimer
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with ErbB4 after NRGI binding, are expressed in both Sertoli and germ cells at all
spermatogenic stages (Abe et al., 2008) and in contrast to ErbB2, the expression of ErbB4 is
more abundant at the spermatogonial stage than in the primary spermatocyte stage, indicating
that nNRGI and its receptor ErbB4 show similar expression patterns in spermatogenetic stages
ln newt testls.
    Addition ofFSH alone in vivo and in vitro can stimulate newt spermatogonial proliferation
and their differentiation into primary spermatocytes by activating its receptor expressed on
Sertoli cells (Abe, 2004). What factors produced by Sertoli cells downstream ofFSH might
stimulate spermatogonial proliferation and their differentiation into primary sperrnatocytes? Our
current study strongly suggests that one of such factors is nlg-NRGI because it is highly
upregulated by FSH and the stimulative effeot of FSH on spermatogonial proliferation was
significantly suppressed by the antibody against nNRGI-EGF in reaggregate culture. However,
the antibody did not inhibit the effect ofFSH completely, which may indicate the involvement of
other growth factors such as SCF. Whether nNRGI alone or in combination with other factors
can induce the differentiation of spermatogonia into primary spermatocytes remains to be
clarified.
    In adult organism, reproduction is one of the most intriguing aspects of development.
lmprovement to our knowledge on the molecular basis of spermatogenesis could lead to
treatments fbr male fertility. In this point, our finding that FSH induces the expression of nfg-
NRGI in Sertoli cells and recombinant nNRGI can promote spermatogonial proliferation by
acting directly on spermatogonia as well as through somatic oells may help to pave the way for
understanding the mechanism of spermatogenesis.
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2.4 EXPERIMENIrAL PROCEDURES
2. 4. 1 Animals and Rengents
    Adult male newts, Cpm7ceprs IzJirnhogaste4 purchased from a dealer (Hamamatsu Seibutsu
Kyozai, Hamamatsu, Japan), were kept at 70C in the dark. Newts to be used fbr experiments
were transferred to 220C and fed frozen 71abijZi)c All chemicals were obtained from Nacalai
Tesque, Kyoto, Japan, unless otherwise stated.
2.4.2 cDNA nu'croarray analysis, cDIVA cloning and RT,PCII
    Total RNA was extracted from newt testes containing the stages ofspermatogonia and early
primary sperrnatocytes by homogenization in ISOGEN (Nippon (lene) using a Dounce
homogenizer. cDNA was reverse transcribed with oligo-d(T) primers and random hexamers by a
reverse transcriptase Superscript M (lnvitrogen);
    Microarrays carrying 5321 independent cDNA clones were made and these clones were
hybridized with Cy3- or Cy5-labeled cDNA probes prepared from total RNA (CyScribe First
Strand cDNA Labeling kit, (iE Healthcare), which had been extracted from the testes ofnewts
irLjected with FSH or vehicle, respectively. Fluorescent signals were quantified by ScariArray
4000 ((ili Healthcare), and the data were analyzed by using Quant Array software (GE
Healthcare). The cDNA clone (637 bp) enooding NRGI was isolated and the nucleotide
sequence was determined wnh an Applied Biosystems model 310 automated DNA sequencer.
    The cDNA clones encoding nfg-NRGI and nCRD-NRGI in newt testis were isolated by
reverse transcription of tota1 RNA, and subsequent PCR amplification (RT-PCR). PCR was
perfbrrned with ExTaq polymerase (Takara) in the condition fbr 45 cycles at 940C fbr 30 s, 600C
fbr 30 s, 720C fbr 45 s, and fbr 40 cycles at 940C fbr 30 s, 580C for 30 s, 720C for 45 s, using
reverse transcribed cDNA as a template with a sense primer (5'-
CCAAAACTAAAAGAAATCAAGACTCAG-3' and 5'-
AACTCTGAGAAGATTTGCATAATCCCT-3') and an antisense primer (5'-
TTACGTCTACGGCCAATA-3' and 5'-CAGTTACGTCTACGGCCAATACC-3 ') based on the
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nucleotide sequence ofX laevis Ig-NRGIor1 (GenBank Accession No: AF076618) and CRD-
NRG162 (GenBank Accession No: AF142632) reported by Yang et al. (1998, 1999). Each of
the amplified DNA fragments was inserted into pT7Blue vector (Novagen).
    mRNA expression ofnNRGI isofbrms was analyzed by RT-PCR using reverse transcribed
cDNA from tota1 RNA ofthe testis with random hexamers. PCR was perfbrmed for 45 cycles at
600C annealing temperature fbr nlg-NRGI and for 45 cycles at 580C annealing temperature fbr
nCRD-NRGI with a sense and antisense primer specific fbr each isofbrm as fbllows: nlg-NRGI,
5'-CCAAAACTAAAAGAAATCAAGACTCAG-3' and 5'-GTTGCTGCTTGTTATACCGTT-
3'; nCRD-NRGI, 5'-AACTCTGAGAAGATTTGCATAATCCCT-3'and 5'-
GGTGTCACCCCTTTTGGTTG-3'. Each ofthe amplified DNA fugments was analyzed by 2%
agarose gel electrophoresis, and then inserted into pT7Blue vector (Novagen). The nucleotide
sequences were verified by sequencing to show the specificity. Negative controls were
perfbrmed in the RT--PCR reaction mixture without reverse transcriptase. The PCR primers were
purchased from Hokkaido System Science Co., Ltd., Japan.
2.4.3. Separation ofcells at specij7c stage by laser microdissection (llA.L.M:)
    Approximately 10 cysts (about 200 cells) each with the 3'd - 4th generation of early
spermatogonial (EG), the 6th-7th generation of late spermatogonial (LG) and primary
spermatocytes (PC) stage in frozen sections (10 pm) were dissected from newt testicular
fragments using laser microdissection system (P.A.L.M. microlaser, Carl Zeiss).
2.4.4 Real-time quantitative PCR
    cDNAs used in RT-PCR were used fbr subsequent real-time quanthative PCR (RT-QPCR).
Primers were designed using the primer 3 software (Whitehead lnstimte fbr Biomedical
Research, Steve Rozen and Helen J. Skaletsky, 2000). A Roche Light Cycler and SYBR premix
Ex Taq ll (Takara) was used to perfbrrn RT-QPCR Samples were amplified fbr 45 cycles at 95
OC 5 s, 55 OC 20 s, and 720C 15 s, with a sense primer 5'-(]K TGGTGCTGAAGTGTCAAG-3'
and anti-sense primer 5'-ACGGAATCA TTTCCAAGCTG-3 ' fbr nfg-NRGI ; sense primer
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5'-GGK[iK CTTAAATGG(}TGT-3' and antisense primer 5'-GTAAG'TG(K}T TCTGTGG(}TA-3'
for nCRD-NRG; sense primer 5'-AAGAGG(]}AATGTTGCTGGTG3' and antisense primer 5'-
ACTTGAGTGCTTTGGG(K)TA-3' fbr elongation factorl-or (EFI-ct). The amounts of target
genes expressed in a sample were normalized with housekeeping gene EFI-ct as an internal
control, which is given by ACt. ACt is determined by subtracting the average endogenous gene
Ct value from the average target gene Ct value. The calculation of AACt involves subtraction of
ACt value fbr the cases. 2'AACt is the relative expression of the target genes in cases compared to
controls. Three independent experiments data are statistically analyzed by student t test.
2. 4. 5 Erpression plasminls, polythistidin oj jusion protein and antibodies
    To express the recombinant protein of the P-type EGF-like domain of nNRGI as a
poly(histidine) fusion protein in bacterial cells, cDNA encoding amino acid residues 103-161
(nlg-NRGI) was amplified by PCR at 45 cycles at 940C fbr 30 s, 580C fbr 30 s, and 720C fbr
45s using the isolated cDNA inserted in pT7Blue vector as a template with a sense and an
antisense primer 5'-CATATGACA(EK TGGGCCAGGTCAC-3'and 5'-
AT(X}CCAGCTTCTACAAATAA GGzl[[CC=3' designed to provide the PCR product with a
Mel restriction site at the 5'-end and a BamHI restriction site at the 3'-end. The PCR product
was digested by the restriction enzymes and then ligated into a bacterial expression vector
pETI 6b (Novagen) to construct the expression plasmids fbr nNRGI .
    Bacterial cells (Escherichia coli, BL21 (DE3) strain) carrying the expression plasmid were
precultured in LB medium containing 50 pglml arnpicillin at 370C overnight. The culture (O.5
ml) was added into 100 ml LB medium containing 50 ptglml arnpicillin and incubated at 370C to
O.5 of the absorbance at 600 nm, and then 1 mM isopropyl-1-thio-S-d-galactopyranoside was
added. Afier further 3 h culture, the bacterial cells were harvested by centrifugation at 40C. The
poly(histidine)-tagged fusion protein was aennity-purified in a denaturing condition (8 M urea in
binding buffer) by nickel resin (250 pl, Invitrogen) column chromatography according to the
manufacturer's instructions. For proliferation assay, nNRGI -EGF eluted with 400 mh and 500
mM imidazole was refblded by dialysis against 50 volumes of20 mM Tris, pH 8.5, O.1 mM DTT
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fbr 6 h at 40C and fbr additional 6 h against 20 mh Tris, pH8.5 (without DTT). To allow the
fbrmation of three native disulfide bridges ofEGF-like domain, nNRGI was dialyzed overnight
against a redox refolding buffer containing 20 mM Tris, pH 8.5, 1 mM GSH and O.2 mM GSSG
(1vautino et al., 2004). For producing antibody, nNRGI-EGF was dialyzed overnight agamst
PBS (pH 7.5). Protein concentration was determined by Bio-Rad DC Protein Assay Kit
according to the manufacturer's instmctions using bovine serum albumin as a standard.
    To produce polyclonal antibody against EGF-like domain and nfg-NRGI, purified
poly(histidine)-tagged fusion peptide and a peptide corresponding to 14 amino acids from
residues 47 to 60 lpart of Ig-like domain) coajugated with keyhole limpet hemocyanin (KLH)
(lnvitrogen) were used, respectively. Two hundred pg ofthe peptide was used per once to
immunize one mouse (C57BL16 strain). The mice were irijected wnh fbur booster irijections at 7-
day intervals.
    For the purification ofthe antibodies, the antiserum against nNRGI-EGF was mixed with
recombinant nNRGI--EGF protein to absorb the antibody against EGF-like domain and to
remove non-specific antibodies that might have been generated by contamination during the
purification of the recombinant protein. The mixed solution was incubated ovemight at 40C,
centrifuged at 15,OOO x g fbr 1 h and collected supernatant was applied to protein G Sepharose
(GE Healthcare) for further purification.
    The antisera against nfg-NRGI was applied to a NHS-activated HiTrap column (GE
Healthcare), previously coupled with KLH protein (Calbiochem, Germany), to remove anti-KLH
antibody and the collected flowthrough fraction was purified by aMnity chromatography on an
aldehyde-activated Cellufine Formyl column (Chisso Corporation, Japan) previously coupled
with the peptide. Both nNRGI-EGF and nlg-NRGI antibodies were eluted with O.1 M GIy-HCI
(pH 2.5) and neutralized with 1 M Tris-HCI (pH 9.0)
2. 4. 6 ST)SM GE and iminunobloutng
    Fractionated germ cells and somatic cells were homogenized in extraction buffbr (O.2%
Nonidet P-40, 20 mM Tris-HCI (pH 8.0), 1 50 mM NaCl, protease inhibitors (protease inhibitor
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cocktail, Roche) and 1 mM phenylmethylsulfbnyl fluoride) using a Dounce homogenizer. After
centrifugation'at 15,OOO x g fbr 15 min at 40C, each extract (20 pg) was mixed with sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) aLaemmli, 1970) sample
buffer (62.5 mM Tris-HCI, pH 6.8, 25% glycerol, 2% SDS, O.Ol% bromophenol blue, and 5% P-
mercaptoethanol) fbllowed by SDS-10% PAGE and transferred to a polyvinylidene difluoride
(PVDF) membrane atnmobilon-P, Millipore). The membrane was blocked in PBS containing
5% skim milk and O.1% Tween-20 fbr 1 h at room temperature. Anti-nfg-NRGI and anti-
nNRGI-EGF absorbed with or without 250 pg and 400 pg peptide antigens, respectively, were
used at 1:500 dilutions. Anti-His-tag antibody (GE healthcare) was used at 1:200 dilutions. HRP-
coajugated anti-mouse IgG ((IE Healthcare) was used as a secondary antibody at 1:2000
dilutions. Proteins were detected using an enhanced chemiluminescence reagent (ECL; GE
Healthcare).
Z4. 7 Organ culture, .fractionation ofsomatie and gema ceds, reaggregate eutrure ofgenn cells
with or without somatic eetls
    Organ culture oftesticular fragments containing only spermatogonial stage was perfbrmed
as deseribed before (Abe et al., 2002). Four fragments of the testes were placed on each
nucleopore filter (Coaster, Cambridge, MA). These testicular fragments were cultured fbr 1 week
at 180C in 2 ml L-15 medium supplemented with O.1 % BSA, and with or without O.2 pg/ml of
porcine FSH (National Hormone & Peptide Program, Harbor-UCLA Medical Center, CA), and
with or without various concentrations ofnNRGI -EGF. The culture medium was changed once a
week. Reaggregate cultures ofgerm and somatic cells were perfbrmed according to Ito and Abe
(1999). Testes were dissociated by O.1% collagenase (type N-2, Nitta Zaratin Co. Japan) for 2 h
at 220C. The cell suspension was filtrated through a 50 pm nylon mesh filter, and dead cells and
reticulocytes were removed by centrifugation at 1OO xg fbr 1O min in 25% Nycodenz solution on
which dissociated cells were overlayered. The live ce11s remaining on the 25% Nycodenz
solution were recovered and washed in L-1 5. The dissociated cells were reaggregated by rotation
culture (70 rotations/min, R-30, TArTEC, Japan) fbr 1 .5 h qt 200C, fbllowed by cenuifugation in
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a O.5 ml siliconized tube (Assist, Japan) (3v"5×105 cellsltube) at 100 xg fbr 5 min. The cell
pellet fbrrned was carefu11y recovered and put into a collagen (Cellmatrix type I-P, Nitta Zaratin
Co. Japan, 2.4 mglml) in 1 x L-15 at pH 7.4. The collagen solution containing a reaggregate was
then placed on a nucleopore filter fbr 1 h until collagen hardened and the filter was floated on L-
15 medium like organ culture.
    To see the effbct of the antibody against nNRGI -EGF on spermatogonial proliferation in
reaggregate culture of sperrnatogonia with somatic cells, the oultures were preincubated with or
without nNRGI-EGFantibody (2.5 pglml) or norrnal mouse IgG (2.5 pglml) for 1 day befbre
addition ofFSH or nNRGI-EGF.
    For analysis of cell type-specific expression of NRG mRNA and protein, germ cells were
separated from somatic cells (mostly Sertoli cells) as described above. After recovering the live
cells remaining on the 25% Nycodenz solution they were put into a 150 mm plastic culture
dishes (#1013, Falcon) that had been coated with O.3 mghn1 oollagen (the original solution was
diluted 1O times with sterile water) at 1 x 106 cellsldish in 5ml L-15 medium with O.1 mM EGTA
and O.1% BSA. When the culture dishes were placed in a incubator at 180C overnight, somatic
cells adhered to the bottom of the dishes. The supematant containing spermatogonia was
recovered, then, after pipetting, put into another 150 mm plastic culture dish coated with
collagen, and incubated fbr further6h at 180C. The recovered supematant, containing only
germ cells (purity was about 90%) was incubated in tl)e absence or presence ofFSH (200 ng/ml)
fbr 24 hours. The dishes, containing somatic cells, were cultured fbr 1 week to allow the death of
contaminated gerrn cells and then incubated in the absence and presence ofFSH (200 nglml) fbr
24 hours.
    For reaggregate culture of spermatogonia only, spermatogonia was purified using
differential adhesiveness ofgerm cells and somatic cells to collagen and the recovered gerrn cells
was put through 30 pm nylon mesh filter, centrifuged at 100 x g for 5 min. After washing with
L-15 medium, the reaggregate cultures containing sperrnatogonia only were prepared as
described above.
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2.4. 8 Mstology and cellprolijleration activity
    The cultured testicular fragments and reaggregates were fixed in Bouin solution, dehydrated
in graded ethanols, embedded in paraffin and sectioned serially at 5 pm thickness. The secuons
were treated with xylene, dehydrated in an ethanol series, and stained with Delafield
hematoxylin fbllowed by eosin.
    For measurement of cell proliferation activity, 5-bromo-2-deoxyuridine (BrdU) was added
to the organ culture for 6 h before fixation and detected with a kit according to the
manufacturer's instructions (Amersham Pharmacia Biotech, Buckinghamshire, England) as
described befbre (Abe et al., 2002). The proliferation activity was expressed as a percentage of
BrdU-positive cysts among all the cysts in 3 fragmentslsection x 4 sections each of which was
derived from every 5 sections. The average value ± SE was obtained from 3 experiments. The
activity in the reaggregate cultures of spermatogonia with somatic cells and of spemiatogonia
only was measured as a percentage ofthe number ofBrdU-positive spermatogonia among all the
living cells within 105 pm2 in a sectionx4 sections. The average value ± SE was obtained from
3 experiments.
2. 4. 9 SZadstics
    Cell proliferation activities were analyzed by the Student's t test. Probability (P) values
<O.05 were considered to be statistically significant.
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3.1 INTRODUCTION
    The ErbB family of receptor tyrosine kinases (RIKs) are transmembrane receptors
characterized by the presence of a conserved tyrosine kinase domain in their intracellular part,
which is either a single or a split kinase domain (Stortelers et al., 2003). There are fbur members
of this family: EGFR/ErbBllHERI, ErbB21Neu[HZER2, ErbB3ZHER3 and ErbB41HER4. All
ErbBs have in common an extracellular ligand-binding domain organized into four subdomains
(I, ll, llI, IV), a hydrophobic transmembrane region and a cytoplasmic protein tyrosine kinase
domain (Fig.3.1)
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Figure 3.1 Schematic representation of the four
ErbB receptor tyrosine kinases Within the
extracellular region the subdomains I and III and the
cysteine-rich subdomains II and VI are indicated. The
percentages refer to the amount of sequence homology
with the corresponding domain of ErbB-1. The
defective kinase domain of ErbB-3 is indicated by a
cross (IF nom Stortelens, 2003).
    Under normal physiological conditions, activation of the ErbB receptors is controlled by
spatial and temporal expression of their ligands, members of the EGF-related peptide growth
factor family (Peles and Yarden, 1993; Riese and Stern, 1998). These peptides are produced as
transmembrane precursors and the ectodomains are processed by proteolysis leading to shedding
ofsoluble growth factors (]Massague and Pandiella, 1993). There are a number ofErbB-specific
ligands, each of which contains an E(]ilF-like domain that confers binding specificity, allowing
them to be divided into three groups (Fig. 3.2). The first group includes EGF, amphiregulin (AR)
and transforming growth factor- or (TGIF-ct), which bind specifically to ErbBl ; the second group
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betacellulin (BTC), heparin-binding EGF (HB-EGF) and epiregulin (EPR),which exhibit dual
specificity in that they bind ErbBl and ErbB4. The third group is composed ofthe neuregulins
(NRG) and forms two subgroups based upon their capacity to bind ErbB3 and ErbB4 (NRG-1
and NRG2) or only ErbB4 (NRG-3 and NRG-4). Despite the abundance ofligands identified for
these three ErbB receptors, no direct ligand fbr ErbB2 has been discovered (Holbro et al., 2003).
     Ligand binding to ErbB receptors induces fbrmation of homo- and hetero-dimers leading
to activation ofthe intrinsic kinase domain and subsequent phosphorylation on specific tyrosine
residues within the cytoplasmic tail. These phosphorylated residues serve as docking sites for a
variety of signaling molecules, whose recruitment leads to the activation of intracellular
pathways, including the mitogen-activated protein kinase (moK) and the phosphatidylinositol-
3-kinase (PI3K) pathways (Olayioye et al., 2000; Yarden and Sliwkowski, 2001). Analyses of
the phosphotyrosine context in the cytoplasmic regions of different ErbB receptors showed the
signaling redundancy as well as specificity between them (Holbro and Hynes, 2004). The Shc-
andlor Grb2-activated MAPK pathway is a common target downstream of all receptors
(Olayioye et al., 2000). Similarly, PBK pathway is directly or indirectly activated by most ErbBs
(Soltoffand Cantley, 1996). However, signaling eD<tent is dependent upon the receptor, because
e.g., ErbB3 couples panicularly well to PBK pathway because of its multiple p85Pi3K docking
sites (Fedi et al., 1994; Prigent and Gullick, 1994), whereas ErbB4 directly recruits p85Pi'3K only
if distinct isoforms are available (Elenius et al., 1999). Other cytoplasmic docking proteins
appear to be recruited by specific ErbB receptors and less exploited by others (Jorissen et al.,
2003). ErbB3 is known to be an impaired kinase due to substitutions in critical residues in its
kinase domain (Guy et al., 1994) and it only becomes phosphorylated and functions as a
signaling entity when dimerized with another ErbB receptor (Kim et al., 1998). On the other
hand, ErbB2 is only activated following its hetero-dimerization with another ligand-bound ErbB
receptor, under normal conditions. ErbB2, however, has a central role in the family since it is the
preferred dimerization patmer for other ErbBs (Tzahar et al., 1996; Giaus-Porta et al., 1997).
Unlike homo-dimers, which are either inactive (ErbB3 homodimers) or signal weakly, ErbB2
containing hetero-dimers have attributes that prolong and enhance downstream signaling
pathways (Beerli et al., 1995; Graus-Porta et al., 1995) (Fig. 3.2).
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Figure 32 The ErbB signaling network Ligands of.the EGF family bind to their receptors, causing the fbrmation
ofdiffkirent ErbB dimers. ErbB2 which has no direct ligand, inducing homo-dimerization, needs a partner to acquire
signaling potential (indicated by the encireledP). However, overexpression ofErbB2 in human tmors can
circumvent this requirernent. Moreover, ErbB3 homodimers cannot signal becEnise the receptor has impaired kinase
activity. Following receptor activation, various molecules (violet) with adaptor or enzymatic imctions are directly
reeruited to the ErbBs. These then activate downstream signaling components (dork blue), which ultimately lead to
changes in the activity of multiple nuclear transcription factors (yellow). For illustrative clarity, we have omitted
many components in each of the signaling layers. FOX; forkhead transcription factor, Ets; members of this
transcription factor family (Holbro andllynes, 2004).
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    EGF-like ligands seem to be able to interact with more than one receptor, albeit with 1arge
difurences in binding aennities (Fig. 3.3). For instance, EGF and BTC can activate cells
expressing ErbB2 and ErbB3 in the absence of ErbBl, although only at supraphysiological
concentrations <Pinkas-Kramarski et al., 1998; Alimandi et al., 1997). Likewise, EGF and TGFct
have low proliferative activity on cells that coexpress ErbB2 and ErbB4 (Wang et al., 1998). Of
particular importance is the notion that NRG isofbrms diffbr both qualhatively and quantitatively
in their abilities- to bind and activate distinct ErbB combinations, whereby the P isoforms
generally signal through a broader spectrum of ErbB dimers than the ct isofbrms, NRG-IP
displays at least one order ofmagnimde higher binding aennity fbr ErbB3, ErbB4, ErbB21ErbB3
and ErbB2/ErbB4 complexes relative to NRG-la, and unlike the latter, was able to
transphosphorylate ErbB3 via heterodimerization with ErbBl (Pinkas-Kiramarski et al., 1996;
Hobbs et al., 2002; Jones et al., 1999). The increased aflinity ofNRG-1P compared to NRG-1ct is
accompanied by an increased mitogenic potency in tumourigenic cell lines of various origins.
This diflierence in activity has been dedicated to the seven C-terminal residues in the EGF
domain (Whoriskey et al., 1998). Funhemiore, both NRG-2 isofbrms can bind and activate
heterodimers of ErbB2 and ErbB4, but only NRG-2P induces ErbB4 tyrosine phosphorylation
and biological responses in cells that express only ErbB4 (Hobbs et al., 2002). Although NRG-
2P binds only weakly to ErbB3, it stimulates ErbB3 tyrosine phosphorylation through
heterodimerization with either ErbB2 or ErbBl in MDA-MB-468 breast cancer cells (Crovello et
al., 1998; Hobbs et al., 2002; Jones et al., 1999; Pinkas-Kramarski et al., 1998). The receptor
specificity ofthe other NRG ligands appears restricted to ErbB4. 0ne group reported that also
NRG-3 would be able to activate ErbB21ErbB3 heterodimers, although others did not observe
NRG-3-induced signaling through other receptors than ErbB4 (Hijazi et al., 1998; Hobbs et al.,
2002).
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Figure 3.3 The differential abilities of EGF-like growth factors to interact vvith distinct ErbB receptor
combinations The greyscale is indicative fbr the relative binding affinity and activity mediated by ligands, with
black representing high affinity ligands (IC50 Sl nM) and white low athnity ligands (>> 1 pM). ND, not
deterrnined. ln case of the ErbB3 homodimer only the bindmg abilities are depicted, as this dirner is defective in
signal transduction (IF>rom Stortelens, 200sp.
    Ligands execute their biological functions by the fbrmation of distinct receptor
combinations. The differential ability of ligands to form distinct ErbB receptor combinations
underlies the complexity in signaling potential. A single growth factor can mediate diverse
biological responses depending on the cell type and the relative expression levels of different
ErbB receptors. For instance, NRG jnduces cell growth in breast cancer cells expressing normal
levels ofErbB2 (such as T47D and MCF-7), and growth inhibition and apoptosis in cells over-
expressing ErbB2 (including SK BR3, AU565, and ]Nfl)A-MB-453) (Daly et al., 1997; Guerra-
Vladusic et al., 2001).
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    As receptors fbr mitogenic growth factors, ErbBs were long suspected of involvement in
human cancer, and such connections were substantiated through multiple 1ines of investigation
(Stern, 2003). The finding that they have essential roles in normal physiological processing
during development in various system (nervous, cardiovascular or gastrointestinal) (Prigent and
Lemonie, 1992; Stem, 2002) led to the discovery of ErbBs in reproductive system. ErbB3 and
ErbB2 receptors are expressed in mouse primordial germ cells (PGCs) in both male and female
genital ridges (Toyoda-Ohno et al., 1999), ln rat testis, expression of all ErbB receptors was
shown in different population of testicular somatic cells and in seminiferous tubules dissected
from all spermatogenic stages (Hoeben et al., 1999). ln support of this report, expression of
ErbB3 and its primary signal transducer, ErbB2, was shown in fractions of purified
spermatogonial gerrn cells (Hamra et al., 2007). Partial cDNAs encoding ErbBl, ErbB2 and
ErbB4 have been isolated from newt testis and mRNA expression of these receptors was detected
in all spermatogenic stages as well as in both somatic and gerrn cells, while the expression of
ErbB4 was much higher at spermatogonial stages than sperrnatocyte stage (Abe et al., 2008).
   ln order to determine the receptors which are responsible fbr the nNRGI-induced
spermatogonial proliferation in newt testis, several inhibitors fbr each receptor were used in
various culture systems and their expressions were examined in different spermatogenic stages
and cell types. To clarify the signaling pathways mediated by nNRGI, the effk:ct ofthe inhibitors
selectively inhibit PI3K and MAPK pathway was analyzed, in newt testis.
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3.2 RESULTS
3.Z1 ,FitnctionalEkbB receptors executed in IVRGI-inducedprolijZeration
   To determine the fUnctional ErbB receptors which panicipate in NRGI-induced
spermatogonial proliferation, we examined the effect of their inhibitors in organ (Fig. 3.4) and
reaggregate culture (Fig. 3.5) of the testes treated with nNRGI. in organ culture system,
sperrnatogonial proliferation was remarkably suppressed by both AG879 (Fig.3.4B) and
PD153035 (Fig. 3.4C), which inhibit specifically ErbB2 and ErbB4, respectively, in a
concentration-dependent manner. The inhibitory effbct of AG1478, ErbBl inhibitor, was less
effective compared with the ErbB4 and ErbB2 inhibitors (Fig. 3.4A), indicating that indirect
promotion of the spemiatogonial proliferation by nNRGI is mediated via ErbB2 and ErbB4
receptors in somatic cells. Since nNRGI can not act on germ cells directly due to size-selective
barrier fbrmed by Sertoli cells in organ culture (Jin et al., 2008), we perfbrmed reaggregate
culture, in which size-selective banier was destroyed by dissociation ofthe testis ato and Abe,
1999) aFig. 3.5). The lowest concentrations of ErbB2 (Fig. 3.5B) and ErbB4 (Fig. 3.5C)
inhibitors were effective in decreasing the number of proliferated spermatogonial cells in
reaggregate culture, demonstrating that nNRGI-induced spermatogonial proliferation is
mediated by ErbB2 and ErbB4 receptors directly andlor indirectly via the activation of somatic
cells. Notably, the promotion ofspermatogonial proliferation induced by FSH was also inhibited
by the ErbB2 and ErbB4 inhibitors in a concentration-dependent manner.
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Figure 3.4 Concentration-dependent effk}cts of ErbB inhibitors on nNRGI-induced spermatogonial
prolhration in organ culture Testicular fragnierits containing spamatogonial stage treated without (-) or with (+)
various conceritrations of A) ErbBl-specific inhibitor (AGI478), B ) an ErbB2-spechic mhibitor (AG879) or C)
ErbB4 inhibitor (PDI53035) were cultured fbr. 1 week in the absence (control) or presence of either FSH (2oo
nglml) or nNRGI (350nrvD, fbllowed by BrdU incorporation assay. ** P< O.05, * P < O.Ol
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Figure 3.5 Effk cts of ErbB inhibitors on nNRGI-induoed spermatogonia1 proliferation in reaggregate culture
Reaggregates were cultured fbr lweel< at 18aC in the medium containing without (-) or with (+) A) ErbBl-specific
mhibitor (1prvD, B ) an ErbB2-specific inhibitor (500nrvD or C) ErbB4 inhibitor (500 nM) in the absence (control) or
presence of either FSH (200 nglml) or nNRGI (350nM), fo11owed by BrdU incorporation assay. "* P< O.O1, * P < O.05
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3.2.2 Fitnctional intracentilar signaliugpathuays aetivated in nlVRGI-indueedprolijTeration
   As homo- or hetero-dimerization of the ErbB receptors lead to the activation of distinct
signaling pathways, we aimed to identify intracellular signal transduction pathways implicated in
nNRGI-induced spermatogonial proliferation. To this end, dose-dependent influences of the
moK and PI3K inhibitors was examined in organ culture (Fig. 3.6) and reaggregate culture
(Fig.3.7) system treated with nNRGI . The number of proliferated germ cells induced by nNRGI
was markedly decreased by PI3K inhibitor, LY294002 (Fig. 3.6A and 3.7A), while the moK
inhibitor, PD98059, was less effective in suppression of the germ cell proliferation (Fig. 3.6B
and 3.7B) in both organ and reaggregate culture system. On the other hand, FSH-induced germ
cell proliferation was suppressed by both moK and PI3K inhibitor.
64
CZtapter 3
       A
        5S      g
      pt ID      g ,,
      a      - ee      'g      ge      gf:
Ly2g4oo2 SO[]lilY
      10 ltM
,IU3K inhibitorLT12940 02
 Centrol FSH
-+ -- --+---+- -- +---+ ---
  riNRLGI
L +--- - + -+---+
  B
g 50
" le･8g.
tF ie
g.,i
  '
500riM
 2pM .
AtL4RKinhibitor"PD98059
PD98059
T
*
**. .
T
.
Cc)rrtrol
  +
+
  FSH
-+
   riNRGI
--+-+ - - +
Figure 3.6 Dose-dependent effbcts of PBK and nvK inhibitors on nNRGI-induced spermtatogonial
prolifbration in organ cul"ire Testicular fraginents containing spermatogonial stage were cultured fbr 1 week in
the medium without (-) or with various doses of A) PI3K-specific inhibitor (LY294002) or B) MAPK-specific
                   'inhibitor (PD98059) in the absenoe (control) or presence of either FSH (200nghn1) or nNRGI (350nlvO and
                                                                  'fo11owed by BrdU incorporation assay. ** P< O.05, * P < O.O1
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Figure 3.7 Effbcts of PI3K and MAPK inhibitors on nNRGI-induced spermtatogonial proliferation in
reaggregate culture Reaggregates were cultured for 1 week at 18 OC in the medium without (-) or with (+) A)
PI3K-specific inhibitor, LY294002 (50CtnM) or B) MAPK-specific inhibitor, PD98059 (500n)vD in the abserice
(control) or presence of either FSH (200nglml) or nNRGI (350n)vD and fbllowed by BrdU incorporation assay. * P
< O.05
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3.2.3 E17Zict ofthe inhthilors onpurij7ed spermangonia
    nlsuIGI induces the proliferation of spermatogonia by acting indirectly via somatic cells
and directly on spermatogonia. To reveal ErbB2 and ErbB4 receptors and PI3K signaling
pathway are activated by nNRGI directly in spermatogonia, we used the inhibitors in
reaggregated culture of purified spermatogonia (Fig. 3.8). The suppression of spermatogonial
proliferation was seen when ErbB2 or ErbB4 inhibitor (Fig.3.8A) and PI3K inhibitor (Fig. 3.8B)
were added in the medium containing nNRGI, which shows the direct action of nNRGI on
sperrnatogonia is mediated by ErbB2 and ErbB4 receptors signaling mainly via PI3K pathway.
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Figure 3.8 Etfects of the inhibitors on purified spemiategonia Reaggregates were cultured for 5 days at 1 8 OC in
the medium without (-) or with (+) A) ErbB2 inhibitor, AG879 (500n}vD; ErbB4 inhibitor, PD153035 (500nM) or B)
PI3K-specific inhibitor, LY294002 (500nM); MAPK-specific inhibitor, PD98059 (5oonM) in the abserice (control)
or presence ofeither FSH (200nglml) or nNRGl (350n)vD and followed by BrdU incorporation assay. * P < O.05
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3.2.4 Expression ofthe E7bB2 and E7bB4 in dijrerent ce" mpes and spermatngenic stnges
    We examined the expressions ofErbB2 and ErbB4 in the testicular somatic and germ gells
(Fig. 3.9A) and at various spermatogenic stages (Fig. 3.9B), to investigate their temporal and
spatial expressions during the sperrnatogenesis. Both ErbB2 and ErbB4 were expressed in all the
stages and in both somatic and germ cells, However, ErbB4 expression was much higher in the
spermatogonial germ cells compared with somatic cells and primary spermatocytes (I¥ig. 3.9).
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Figure 3.9 Expression of ErbB2 and ErbB4 in different spermatogenic stages and cell types A) Fractionated
somatic and germ cells containing spermatogonial and primary spermatocyte stages were lysated and 10 pg of each
cell lysates were immunoblotted with the ErbB4 (upper panel), ErbB2 (middle panel) or anti-Pactin (lower panel)
antibody. B) Cell lysates (10 pg) isolated from cells in early spermatogonial (EG), in late sperrnatogonial (LG) and
the primary spermatocyte stage (PC) immunoblotted with the appropriate antibodies.
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3.3 DISCUSSION
   ln newt testis, nNRGI was identified as one of the FSH-upregulated genes and shown to
induce the proliferation of spermatogonia by direct action as well as indirect action via somatic
cells which are activated by FSH. The present results demonstrate: first ErbB2 and ErbB4 are
the functional receptors in the sperrnatogonial proliferation induced by nNRGI; second, the
expression of these receptors was detected in both somatic and germ cells at all the
spermatogenic stages examined; and third, nNRGI-activated receptors lead to the signaling of
mainly PBK intracellular pathway in newt testis.
    Treatment of the testis with inhibitors specific fbr ErbB2 and ErbB4 receptors resulted in
suppression of germ cell proliferation induced by nNRGI, suggesting that the action of nNRGI
on germ cell proliferation was mediated by ErbB2 and ErbB4 receptors in newt testis. However,
since no direct ligand fbr ErbB2 has been discovered so far (Holbro and Hynes, 2004), nNRGI is
thought to bind directly to ErbB4 and induce the fbrmation ofits hetero-dimerization with ErbB2
or homo-dimerization with itsel£ AG1478, an inhibitor specific for ErbBl, slightly suppressed
spermatogonial proliferation induced by nNRLGI. Considering the activation of distinct ErbB
combinations by NRG isoforms, ErbBl may play a role in spermatogonial proliferation via
hetero-dimerization with ErbB2 or ErbB4 receptors. The repression of FSH-stimulated
proliferation by ErbBl inhibitor may suggest the existence of other EGF family ligand, which
induce the proliferation of spermatogonia via somatic cells activated by FSH. ln organ culture,
concentration-dependent responses ofsuppression in the spermatogonial proliferation induced by
nNRGI to all ofthe ErbB inhibitors vvere stronger than that induced by FSH, suggesting that low
concentrations of the inhibitors are enough to suppress nNRGI-mediated activity ofthe ErbB2
and ErbB4 in somatic cells, while their high concentrations are necessary fbr FSH-mediated
activity of the receptors in spermatogonia. As FSH receptor is expressed only in somatic cells
(Abe, 2004), and FSH can not stimulate the proliferation directly on spermatogonia, the partial
inhibition ofFSH-induced proliferation may suggest the existence ofother factors, which lead to
activate different receptor signaling, in somatic cells.
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   The expression analyses revealed that the nNRGI receptors, ErbB4 and ErbB2, are
expressed in somatic cells as well as in germ cells at the spermatogonial and spermatocyte
stages. This result was consistent with the mammalian testis that transcripts, encoding ErbBl,
ErbB2, ErbB3 and ErbB4 are selectively expressed in diflierent populations of isolated somatic
testis cells (Leyding, Sertoli and peritubular) and in seminiferous tubules dissected from all
stages ofthe rat epithelial cycle (Hoeben et al, 1999; Wahab-Wahlgreen et al., 2003). In support
ofthis, Hamra et al (2007) showed that transcripts encoding the neuregulin receptor ErbB3, and
its primary signal transducer, ErbB2, are enriched in fractions ofpurified spermatogonia, while
transcripts fbr ErbB4 are enriched in fractions of tubular somatic cells. ErbB3, however, could
not be detected in newt testis (Abe et al., 2008). Previously, we have shown that nNRGI can
promote spermatogonial proliferation by indirect action via somatic cells in organ culture
system, in which the molecules 1arger than 1.9 kl)a could not penetrate into the cysts due to the
existence of the blood-testis banier formed by Sertoli cells (Jin et al., 2008). The result showing
the expression ofthe receptors in somatic cells is likely because nNRGI (approximately 7 kDa)
could not penetrate into the cysts to act on spermatogonia in the organ culture and very probably
signal via the ErbB2 and ErbB4 receptors, expressed in somatic cells. On the other hand, the
ability of nNRGI in the direct promotion of spermatogonial proliferation may be explained by
the existence ofthe ErbB2 and ErbB4 receptors in the germ cells.
    interaction ofa ligand with difft)rent ErbB homo- and hetero-dimers offers the possibility of
a broader signaling diversity, as hetero-dimerization leads to an increase in the collection of
signaling proteins recruited by the receptor complex (Graus-Porta et al., 1997; Muthuswamy et
al., 1999). In organ culture, we showed that spermatogonial proliferation induced by nNRGI was
markedly suppressed by PI3K inhibitor, LY294002, in a concentration-dependent manner,
whereas MAPK inhibitor, PD98059, was not so efficient compared wnh the PBK inhibitor. This
result suggests that PI3K cascades function downstream of the ErbB2 and ErbB4 receptors
activated by nNRGI in newt testis. On the other hand, FSH-stimulated proliferation was
suppressed by both MAPK and PBK inhibitor, suggesting both kinase cascades function
downstream of the FSH, which is consistent with the reports in rpammalians that FSH mainly
activate PKB in a PI3K-dependent manner in Sertoli cells (Meroni et al., 2002) and partly
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mediated by the MAPK cascade by activating ERK kinase (Crepieux et al., 2001; Walker and
Cheng, 2005). However, as ErbB receptors, MAPK and PI3K are localized in both somatic and
germ cells, we can not rule out a possibility that these inhibitors used here pass through the
blood-testis barrier into cysts to inhibit the activity ofEGF receptors, MAPK, and PI3K, because
their molecular weight is 1ess than 500 Da (Jin et al., 2008). Hence, inhibitors seems to block the
signaling within both cell types in organ culture, because direct exposure ofspermatogonia to the
inhibitors in purified re-aggregate culture repressed the activation ofErbB2 and ErbB4 receptors
by nNRGI .
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3.4 EXPERIMENTAL PROCEDURES
3.4. 1 Animals and 1teagents
   Adult male newts, CJmops pyrrhogaster, were purchased from a dealer (Hamamatsu
Seibutsu Kyozai, Hamamatsu, Japan) and prepared for experiments as described in chapter 2.
Rabbit polyclonal antibodies to the carboxyl terminus of ErbB4 and ErbB2 were obtained from
Santa Cruz Biotecnology (Santa Cruz, CA, USA). MAPK inhibitor (PD98059) and ErbB2
inhibitor (AG879) were purchased from Calbiochem. EGFR inhibitor (AG1478) and PBK
inhibitor (LY294002) were from Sigma. A pan ErbB inhibitor (PD153035) was obtained from
Biaflin (Kassel, Germany).
3.4.2 Organ culture oftesticular.fragments, reaggregate cuimre qfgene celZs itnith or wtihout
somatic cells and BrdU ineorporation assay
    The immature portions containing late spermatogonial stage were removed from the whole
testes and cut transversely and longitudinally into severa1 pieces (1-2 mm in thickness). Organ
culture and reaggragate cu!tures was perfbrmed as described in chapter 2 with or wnhout ErbB
inhibitors or PBK, MAPK inhibitors at various concentrations in the presence or absence of
either porcine FSH (200 ng/ml) (National Hormone & Peptide Program, West Carson, CA) or
nNRGI (350nM).
   The cultured testicular fragments were prepared fbr cell proliferation assay and the
proliferation activity was examined in the sections by immunohistochemical detection of 5-
bromo-2-deoxyuridine (BrdU) incorporated into replicating DNA in the cells as described in
chapter 2. The frequency ofproliferation was expressed as a percentage (means ± SEM) ofBrdU
positive cysts in the organ culture or BrdU positive cells in the reaggregate culture obtained from
3 independent experiments. Statistical analyses were perfbrmed using student's ttest.
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3.4.3 SleparatiOn of spermatogenic stage, .fractionation of somtztic and germ eells,
immunoblotting
    The immature part oftestes containing early spermatogonial, late spermatogonial or primary
spermatocyte stage was cut transversely into small pieces (1-2 mm thickness) and then each
piece was cut longitudinally (cephalo-cauda11y) into halves. A half of each piece was processed
for histological analyses and the counterpart was used fbr protein extraction fo11owed by
immunoblotting.
   Somatic and gerrn cells were fractionated as described in chapter 2 and then subjected to
immunoblot assay. Immunoblouing was petfbrmed as described in chapter 2 with some
modifications. Fractionated testicular cells and the fragments derived from different
spermatogenic stages were homogenized in RIPA buffer (50 mM Tris-HCI pH 8.0, 150 mM
NaCl, O.1 % SDS, 1 % Triton-X-100) containing freshly added protease inhibitors (complete
protease inhibitor cocktail, Roche) and 1 miN4 PMSF. Lysates were cleared by centrifugation,
resolved on 7.5% SDS-PAGE and electrophoretically transferred to PVDF membrane
(lmmobolin-P, Millipore). The membrane was incubated for 2 hours in PBS containing 5 % skim
milk and O.1 % Tween-20 at room temperature, probed with either EifbB4 or ErbB2 antibodies at
1:2000 dilutions fbr 1 hour and subsequently incubated with HRP-coajugated anti-rabbit IgG
(GE Healtcare). lmmunoreactive bands were visualized using ECL reagent (GE Healtcare).
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4.1 INTRODUCTION
    Over the past years, ErbB receptors have been pursued as therapeutic targets because of
their involvement in various human cancers (Yarden and Sliwkowski, 2001). ErbB signaling
requires spatio-temporally regulated activation as well as down-regulation ofErbB receptors and
down-stream signaling events (Stortelers et al., 2003). inactivation or downregulation ofErbB
signaling is basically achieved through three mechanisms: first regulation of ErbB receptor
activity through threonine phosphorylation; second, receptor internalization and degradation
through the lysosomal and proteasomal pathways, and third, dephoshorylation by specific
protein-tyrosine phospatase (PTP) activity. ln the first mechanism, threonine and serine
phosphorylation ofreceptor protein kinases (ErbBl and ErbB2) in thejuxtamembrane region has
been implicated in the regulation of kinase activity (Countaway et al., 1992; Monison et al.,
1993). Threonine phosphorylation can rescue internalized ErbB receptors from degradation and
diverts them to the recycling pathway a3ao et al., 2000). Protein kinase C (PKC) was fbund to
regulate NRG signaling through the ErbB4 receptor in a negative mamer by the activation of a
selective proteolytic mechanism, involving the release of the ectodomain by cleavage of the
juxtamembrane region. This ectodomain cleavage has been observed only fbr ErbB4 receptors,
although juxtamembrane-isofbrms ofErbB4 have been isolated that are insensitive to proteolytic
processing (Vecchi et al., 1996; Elenius et al., 1997). The cleavage activity liberates the 80 kl)a
ErbB4 cytoplasmic domain from the plasma membrane into the cytosol and this fragment
subsequently translocates to the nucleus to activate transcription factors (Vecchi et al., 1996;
Carpenter, 2003) (Fig 4.1).
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Figure 4.1 Proteolytic cleavage pathway for ErbB4 Proteolytic prooessing is initiated by 12-O-
tetradecanoylphorbol-13-acetate (TPA) or a growth factor and involves different topological mechanisms, but the
same proteases. Ectodomain cleavage involves turnor necrosis factor-alpha.converting enzyme (TACE), a member
of the transmcmbrane ADAM metalloprotease fatnily, while intramembrane proteolysis is affected by y-secretase
(PS-1). Processing by either route produces the oytosolic ErbBZt fragment (s80), which is fbund in the nucleus as
an active tyrosine kinase (from Carpenteag 200sy.
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ln the second mechanism, ErbB receptors are rapidly concentrated as clusters in clathrin-ooated
pits upon ligand binding, fo11owed by internalization into early endosomes and subsequent
recycling or degradation ofthe receptor cornplexes. Recently, NRG receptor degradation protein-
1 (Nrdp), a protein involved in the localization and sorting of ErbB3 and ErbB4, has been
implicated in the downregulation ofthe NRG receptors. Nrdp is a tripanite protein comprising an
atypical RING finger, which has E3 ubiquitin ligase activity, B-box and coiled-coil domain
(Diamonti et al., 2002). Indeed, Nrdpl has been shown to mediate the ubiquitination ofErbB3
and ErbB4 in the presence of UbcH5 and the subsequent delivery to intracellular compartments
fbr proteosomal degradation (Qiu and Goldberg, 2002). ln the last mechanism, the
phosphotyrosine levels of ErbB receptors and signaling components are regulated by the
antagonistic activity of protein tyrosine phosphatases. The phosphatases Shpl (P'IP-IC) and
Shp2 (PTP-ID) contain two SH2 domains in tandem through which they can associate both
directly and indirectly with ErbB receptors and regulate downstream signaling (Vogel et al.,
1993; Tomic et al., 1995). Particularly Shp2 can regulate the kinetics and magnitude ofErbB
signaling in a receptor specific manner, by integrating the Ras-Erk and PI3K signaling pathways
(Zhang et al., 2002; Yu et al., 2002; Yart et al., 2001). Though some molecules or proteins are
identified in the regulation ofErbBl, ErbB2 and ErbB3, less is knovvn about the most recently
characterized ErbB family member, ErbB4 (Junttila et al., 2005).
    Here, we attempted to identify the proteins or molecules which may downregulate or
upregulate the NRGI-induced signal transduction pathways modiated by ErbB2 or ErbB4
receptors in newt testis. To this end, we perfbrmed MALDI-TOF-MS or ESI analyses using
FSH-･treated testes extract co-precipitated with ErbB2 or ErbB4 antibodies. We fbund SAPI55 as
a protein interacting with ErbB4 receptor and isolated a panial cDNA encoding newt SAP155.
First, we examined the expression of newt SAP155 in different spermatogenic stages and
testicular cell types and then using co-immunoprecipitation/immunoblot analysis we
demonstrated their interaction in only primary spermatocyte stages. These resuks may suggest a
possible role of SAP155-ErbB4 interaction in the down-regulation of ErbB4 expression in
prlmary spermatocyte stage.
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4.2 RESULTS
4.2.1 SZrreening ofthe E)bB2- or E7bB4-assoeiatedproteins mpon EgHor PRL treatment
    To identify ErbB2 or ErbB4-associated molecules, immunoprecipitations were perfbrmed
from FSH-treated newt testis, containing sperrnatogonial and primary spermatocyte stages with
polyclonal antibodies raised against C-terminal region of the ErbB2 and ErbB4 receptors.
Proteins coprecipitating with ErbB2 (Fig.4.2A, lane 2) and ErbB4 (Fig.4.2A, lane 3) from FSH-
treated newt testis are shown in Fig. 4.2A. Parallel immunoprecipitations with PRLtreated (Fig.
4.2B) newt testis allowed us to discriminate between FSH-induced ErbB-associated molecules or
PRL-induced ErbB-interacting molecules. A number ofErbB2 or ErbB4-associated proteins in
the range of 66 to 200 kl)a were observed and some ErbB2 or ErbB4-precipitated proteins
diffk)rent from control immunoprecipitations with HA antibody or PRL-treated samples
(Fig.4.2A, dots) were selected for funher analysis.
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Figure 4.2 Co-immunopr'ecipitation with ErbB2 and Eri)B4 antibodles upon FSH or PRL treatment
Newt testis extract was prepared 24 h after FSH (A) or PRL (B) iiijection and 3 mg of each sample extract was
precipitated with 20 pg of the ErbB2 (lane 2), ErbB4 aane 3) or HA antibody (lane 4). Precipitated proteins (lane 2-
4) and molecular mass standards aane 1) were separated by SDS-PAGE, stained with Sypro Ruby gel staining and
visualized with Typoon 94oo scanner.
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4.2.2 Identipcation ofthe S!IM55 as an ElrbB4associatedprotein
   Co-immunopreciphated samples from FSH-treated newt testis were separated in
polyacrylamide gel and stained with deep purple staining to increase the sensitivity (Fig. 4.3).
The protein bands (lane 2, number 1-3 and lane 4, number 1-4) were isolated from the
polyacrylamide gel and peptide mass spectrum was obtained fbr each tryptic digestion products
by using MALDI or ESI analyses. The mass spectrum fbr the protein band lane 4, number 1 was
shown in Figure 4.4. Identified proteins from other bands were listed in Table 1 and Table 2. The
protein band (lane 4, number 1) having the highest score among all analyzed proteins was
matched to those of mouse SAP155 asono et al., 2001), a component of the spliceosomal
complex A (Schmidt-Zachmann et al., 1998) (Fig. 4.5). To obtain amino acid sequences, some
peptides were subjected to second mass spectmm analyses (Fig.4.6) and the result was consistent
with previous mass analysis (Fig. 4.5). To funher validate an association with the ErbB4 or
ErbB2, immunoblotting was perfbrmed with identical sample (Fig.4.7). Results confirmed that
SAPI 55 specifically associated with the ErbB4 and in a small amount with ErbB2, could only be
seen in longer exposure.
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Figure 4.3 ErbB2- or ErbB4-precipitated proteins from FSH-treated newt testis 10 pl (lane 1,3,5) and 20 pl
(lane 2,4,6) of immunoprecipitated samples with ErbB2 (lane 1,2), ErbB4 aane 3,4) and HA (lane 5,6) antibodies
were electrophoresed on 7.5 9,6 SDS-PAGE, stained with Deep purple total protein gel stain and the protein bands
from number 1-3 tbr ErbB2-precipitated sample and from number 1-4 for ErbB4-precipitated sample were extracted
from the gel and fo11owed by trypsin (O.O1pg) digestion at 370C. Molecular mass marker was shown on the left.
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Band
No:
IdentityMass in DaMascot ScoreQueries matehedSp cies DatabaselAccessionNo:
1
2
3
SMCIu
HSP90P
HSP70
143127
83 142
70827
54
31
36
25
19
15
Mouse
Mouse
Mouse
Swiss-Proti Q9CU62
Swiss-ProtXPI 1499
Swiss-ProVP63017
Table 1: ErbB2;bindmg proteins identdied by MALDI-TOF analysis
Band No:IdentityMass in DaMascct ScoreQueries matchedSpeclesDatabaseLAccession Nb:
1.
2.
3.
3.
4.
SAP155
SAP130*
HSP90P
MCM7
HSP70
145724
135507
83142
81826
70827
52
306
31
48
44
30
8
19
19
12
  Mouse
  Human
  Mbuse
Xenopus laevis
  Mouse
Swiss-Proti Q99NB9
Swiss-Proti Q1 5393
Swiss-Prot/Pl1499
         '
Swis -ProtiQ91876
Swiss-ProtfP6301
rable 2: ErbB4-binding pioteins identified by MALDI-TOF analysis. " The protein identified by ESI
analysis.
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Figure 4.4 rmIDI mass spectrum ofthe peptides obtained from ErbB4-precipitated protein number 1
The peptides were reconstituted with A) 309i6 acetonitrile and B) 50% acetonitrile, containing O.1% TFA, enclosed
with 1 pl of3pg/pl matrix (a-cyano-4-hydroxycinnamic acid) and then subjected to MALDI-TOF-MS analysis.
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            Nurotper ot rnass vaiues rmatched:3e
            Sequence Coverage:19}
            Matcheot peptiotes shewn in })ola rea
              1 MAKIA}ff[]HEB IEA"XREIPG KKAALDSAOG VGLDSTGYYD PEIYGGSPSR
             SI FAewTglM TELEDDDbDY S$ST$bLSqK K?GYHAgVAL LNDXPQSTEQ
            lel YP?EAEUR?V X:AOREDEYK KHRRTMZ:$P eRLBPEADGG KTPDPKMNAR
            151 TYMVVXREgK LTXgERE:Rg gkAEKAXAGE LKWNGIUMS gPPSKRKRRW
            2Dl DQTAbQtePGA TPKKI,SSscDQ ASrggHe?SL RPIDEWgGKSLK GSEMPGATPG
            251 SKmoPTRSM TPAeA.ATPGR GOeePGHAWPG HG¢AMSSARK NRWDEWPKME           301 RIwrrPGHGSSW AETPRTDR(!Xl; DS!GETPM?G ASKRKSRWDE TPASQMGGSM
           351 PVLe?$KrPge GvePAMNNAWP rPGH:N$MreP EQS9AvaResER E:DERNffCI}ZS
           401 MEEI,bnvPE GYN(V]LPmpnc WPXRTPARK ZTArePrPLGG MrcFHMQrED
           4Sl RrwKSVNDQP SGNnPEtKPB DrOYFDKtLV DVDESNSPE XQRgRK!MKt
           501 LLKXKNgrePP NRXMLRPrT PKARErrGAGP LFNQZIPkLM SPMLEDQERH
           5Sl LZVKV!PRrb YKM"OLVRI}Y VHKrLWrEP LLIBEDwwAR VEGRE!rSNL
           601 AKAAGtaTM! $TMRPBrDNM "EYVRNTMikR ArrAWA$ALG !PSLLPFLKA
           651 VCKSKKSWQA RHTGrXrVeQ rArth{GCAIL PHLRSLVEIX EHGLVDEGgK
           701 VRNSALArA ALAEAATPYg rESFDSVLKP LWK6TRQHRG KGllMrrLKA!
           7Sl GhrbTPImaDAE YtwYYTREIne LXUREF9SP DEEbdKKIVLK VVKQCCGTDG
           BOI VEANYTKTE! LPPeFKHFWQ HRMALDRRNY RQIVDTTVEL ANKVgl"LEXI
           851 SRXVODLKPE AEQYRKNVMS NSKIMGnvLG MDIDHKLEE QLIDGIkYAE
           901 QEQ?TEbSVM LNGFGTVVNA LGKRVKInyiLP QICGTVLblRL NNKSAKVRQP
           Y51 AADllrSRrAV V)EKTCQEeKL MGHL(WLYE liLGEEYPEVL GS:LGAIKA:
          10el VNVIcuHKMT PP:KDLLPRL rPILXNRHEX VQENCXDLVG RXADRGAEW
          1051 SAREma,XCF ELkgLLKAHK XA:RRIKTVNM FaYIIL-(AIGP HDVZ,ATLLNN
          1101 LKVeERQNRV CTTVAZAXVA ETCSPETVLP ALMNEYRVPE ;teIVQNGVLKS
          :251 LSELEEY:GE NGKDYXYAW PLLEDAtwDR DLVHRQVA$A W9HMSkevY
          1201 GFGCED$LN" LgNYVSgPI"VE ETSPHVZgAV NGALEGLRVA :GPeRNLQYC
Figure 45 Identification of SAP155 as an ErbB4-interacting protein The peptides masses were prooessed to a
database search for sequenoe similarity in the NCBI database. Matched peptides were shovvn in bold red.
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Figure 4.7 Validation of MS result The samples (1O pl) irnmunopecipitated witli anti-ErbB4 aane 1), anti-ErbB2
aane 2) and anti-HA (lane 3) were immunoblotted with the anti-ErbB4 (upper panel), anti-SAPI55 (middle panel)
and anti-ErbB2 antibodies. Arrows indicates the positions of appropriate proteins.
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4.2.3 cDNA eloning ofnewt SAP155
   To isolate a newt SAP155 cDNA, we designed 5'- and 3'-primers according to the
sequences of the mouse cDNA (Accession No. AB037890) and cloned through reverse
transcriptase (RT)-PCR. Screening of a newt testis cDNA library gave rise to a clone and
nucleotide sequencing revealed that the clone comained a 2.7-kbp cDNA with an open reading
frame (ORF) encoding 930 amino acids homologous to members ofthe spliceosome associated
protein family conserved among mammals and amphibians. The amino acid sequence of newt
SAPI55 is nearly the same as mouse SAPI55 and Xkinopus 146-kDa protein, showing 99% and
94 % identity, respectively, and is also highly similar to those of gene products from human
(99%) and rat (98%), which were found in the database (Fig. 4.8). Comparison of the amino
acid sequence in the N-terminal region showed the existence of the TP-dipeptide motifs and a
domain containing RWDETP repeat. C-terminal stretch of SAP155 is remarkably highly
conserved among the five species. BLAST homology search with the C-terminal sequence fbund
the PR65 subunit of protein phosphatase 2A with significant similarity The PR65 subunit is
composed entirely of 15 tandem repeats ofa 39 amino acid sequence termed a HEAT motif and
according to a consensus sequence of the HEAT motifs, the panial C-terminal region of newt
SAPI55 was composed of7 tandem HEAT-like repeats.
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Figure 4.8 The deduced amino acid sequence alignment of newt SAP155 with those ofXenopus laevis, mouse,
rat and human. The respective amino acid numbers are shown at the both sides. Identical amino acid residues
among all species are indicated by asterisk. The repeated TP sequences are shown in bold and TP-rich domain in the
N-terrninal region was under1ined. The tandem repeats in the C-ter rninal region was indicated by boxes.
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4.2.4 S7age-specipc and celbmpe specijib expression ofnewt SL4M55
    To examine the expression of newt SAPI55 during spermatogenesis, immunoblotting was
perfbrmed using testis extract derived from various spemiatogenic stages, rich in early (3rd - 4th)
spermatogonia, late (6th - 7th) spermatogonia and primary spermatocytes. The expression ofnewt
SAPI55 was detected in all the spermatogenic stages from early to primary sperrnaticyte (Fig.
4.9A). To show cell-type specific expression of newt SAP155, somatic and germ cells are
fractionated as described previously and immunoblotting was perfbrmed. A single band was
observed in germ cells fraction with the expected size of SAPI55, indicating that in newt testis
SAPI55 was expressed only in germ cells eig. 4.9B).
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Figure 4.9 Expression of SAP155 in diffi:rent spermatogenic stages and cell types A) Cell lysates (10 pg)
isolated from cells with 3rd -4th generation ofearly spermatogonial (EG), the 6th-7th generation oflate spermatogonial
(LG) and the primary sperrnatoeyte stage (PC) were immunoblotted with the indicated antibodies. B) Fractionated
somatic and germ cells were lysed and 10 pg of each cell lysates were immunoblotted with the anti-SAP155 (upper
panel) or anti-Pactin (lower panel).
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4.2. 5 interaction between EbbB4 and SAP155 in dij72irent spermajogenic stages
    To deterrnine the interaction between ErbB4 and SAPI55 in diffbrent spermatogenic stages,
co-immunoprecipitation and immunoblotting experiments were perfbrmed with the ErbB4 and
SAP155 antibodies, respectively. SAP155 was shown to be precipitated only in primary
spermatocyte stage, while ErbB4 existed in all stages (Fig. 4.10A). lmunoprecipitation with the
SAPI 55 antibody was also perfbrmed to confirm the association. ErbB4 protein was detected in
SAP155-preciphated samples only in primary spermatocytes stage eig.4.10B), indicated that
ErbB4-SAP155 specifically interacts only in primary spermatoctes stage in newt testis.
lmmunoprecipitations with HA antibody was perfbrmed using the extract derived from the testis
containing all spermatogenic stages from early spermatogonia to primary spermatocyte as a
control (Fig.4.1OA, B, right lane).
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Figure 4.10 Co-immunoprecipitation with ErbB4 and SAP antibodies in diffi:rent spermatogenic stages
FSH-treated testis extract (500 pg) isolated ffom early spermatogonial (EG), late spermatogonial (LG) and the
primary sperTnatocyte stage (PC) was precipitated with anti-ErbB4 (1pg) or anti-SAP155 (1pg) and with anti-HA
(1pg) or normal mouse serum (NMS) (1pg) as a control. lmmunoblotting was performed with indicated antibodies.
wnole testis contained all sperrnatogenic stages.
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4.3 DISCUSSION
    Iri newt testis, we have shown nNRGI can promote the proliferation of spermatogonia by
activating ErbB2 and ErbB4 receptors, which leads to the induction of mainly PI3K signaling
pathway. Here, we identified SAP155 as one of the ErbB4-binding protein using mass
spectrometry. SAP155, one of the five subunits of the SF3b complex, is a nuclear protein
essential fbr pre-mRNA splicing (Kaida et al., 2007). SAPI55 has been shown to be a substrate
fbr phosphorylation by cyclin E-Cdk2 (Seghezzi et al., 1998) as well as cyclin B-Cdkl (Boudrez
et al., 2002). The interaction ofSAPI55 with cyclin E, a major cell cycle regulatory protein and
an essential component of the Gi-to-S transition in mammalian cells, suggest that the link
between the cell cycle and pre-mRNA processing constimtes a way in which the cell cycle
machinery exerts a growth-promoting eflbct by modulating the splicing activity (Seghezzi et al.,
1998). ErbB4, a transmembrane receptor tyrosine kinase, is subject to a two-step proteolysis
pathway that is stimulated by binding of NRGI (Vecchi et al., 1996). Cell surface shedding
activity ofErbB4 releases an 80-kl)a ectodomain fragment, representing the transmembrane and
cytoplasmic domains, associated with the cell (Vecchi et al., 1996). Second membrane-localized
protease activity, mediated by y-secretase (Ni et al., 2001; Lee et al., 2002), liberates the ErbB4
fragment from plasma membrane into the cytosol and subsequently this fragment translocates to
the nucleus to function as an active tyrosine kinase (Linggi et al., 2006). in newt testis, co-
immunoprecipitation of SAPI55 with ErbB4 suggests the interaction ofthese two proteins in the
nucleus. However, immunopreciphation experiments in diffbrent spermatogenic stages showed
the association between ErbB4 and SAP155 only in the primary sperrnatocyte stage. The
questiop why the interaction does not occur in spermatogonial stages has been still unknown.
One possibility is that, SAPI55 may bind to the C-terminal fragment ofErbB4 in the nucleus at
primary spermatogonial stage, which may inhibit the downstream signaling of nNRGI-induced
ErbB4 activation. Demonstration ofthe 80-kDa ErbB4 fragment translocation from cytosol into
the nucleus in different spermatogenic stages ofnewt testis is necessary to address this question.
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4.4 EXPERIMENrAL PROCEDURES
4.4.1 Animals and Retrgents
   Adult male newts, Cpmops pJtrzhqgasteL purchased from a dealer (Hamamatsu Seibutsu
Kyozai, Hamamatsu, Japan), were kept at 70C in the dark. Newts to be used fbr experiments
were transferred to 220C and fed frozen Tlubij2iJt All chemicals were obtained from Nacalai
Tesque, Kyoto, Japan, unless otherwise stated. Rabbit polyclonal antibodies to the carboxyl
terminus ofErbB4 and ErbB2 were obtained from Santa Cruz Biotecnology (Santa Cruz, CA,
USA). Mouse monoclonal SAP155 antibody was purchased from Medical & Biological
Laboiatories.
4.4.2 Cb-inzmunoprecipitation and Imntunoblotimg
    FSH--treated newt testis, containing all the spermatogenic stages from early gonia to primary
sperrnatocyte, homogenized with mild extraction buffer containing 1% NP40, 1 50 mM NaCl, 10
mh sodium phosphate pH 7.2, 2 mh sodium fluoride, complete protease inhibitor cocktail
(Roche) and 1 mh PMSF using a Dounce homogenizer. Samples were centrifuged at 10,OOO
rpm for 1O min and the supematants were pre-cleaned with appropriate protein A or G-Sepharose
beads ((ilE Healthcare) for 3 h and then mixed with the indicated antibodies fbr ovemight. The
beads were washed wnh extraction buflier and boiled in 2 x SDS loading buffbr. Samples were
separated by SDS-PAGE, transferred into PVDF membrane electrophoretically and subjected to
immunoblotting analysis with the indicated antibodies. After reaction with HRP-coojugated
secondary antibodies, the reacted protein pattern on the membrane was visualized by an ECL
detection system (GE Healtcare).
4.4.3 SI7?RO Ruby andDeep Ptzrple 7btalhotein Gel Slaining
    For SYPRO Ruby gel staining, gels were fixed two times in 50% methanol containing 7%
acetic acid fbr 30 min, stained in SYPRO Ruby protein gel stain (invitrogen) overnight in the
dark and then washed with 10% methanol containing 10% acetic acid fbr 30 min. Gels were
washed twice with water fbr 5 min and scanned by Typoon. For Deep purple staining, gels were
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fixed in 10 % methanol containing 7.5 % aQetic acid overnight, washed with 300 mM Na2C03
containing 35 mM NaHC03 fbr 30 min and then stained with Deep purple total protein gel stain
fbr 1 h in the dark. Gels were stabilized twice in 7.5% acetic acid for 15 min befbre scanning.
The fluorescent images were scanned with Typhoon 9400, visualized and processed as digha1
data with data mining software lmageQuant version 5.2, DeCyder (GE Healthcare) and
ProGenesis Work station version 2005 (PerkinElmer Life Science).
4.4.4 Mass ,SipectromeO )r
    Immunoprecipitated proteins were electrophoresed on 7.5% SDS-PAGE, stained with Deep
purple total protein gel stain (GE Healthcare) and the appropriate bands were excised. The
proteins were digested with O.Ol pg of trypsin (Promega) at 37 OC overnight and the resultant
peptides were desalted by Zip tips Cl8 (Millipore). The samples were then subjected to infusion
nano ESI-QQ-TOF (QSTAR Pulsar i Applied BiosystemsllVDS SCIEX) or MALDI-TOF
(Applied Biosystems 4700 proteomics analyzer) mass spectrometry. Panial amino acid
sequences data, obtained with peptide ion fragmentation due to high collision energy, processed
to a search fbr sequence similarity in the Swiss-Prot or NCBI database using the Mascot Search
software (Mauix Science).
4.4. 5 cDIVA aoniirg and Slaquenciirg
    The cDNA clones encoding SAPI55 in newt testis were isolated by reverse transcription of
tota1 RNA, and subsequent PCR amplification (RT-PCR). Total RNA was extracted from newt
testes, which had been homogenized in ISOGEN (Nippon Gene) using a Dounce homogenizer
and cDNA was reverse transcribed with oligo-d(T) primers and random hexamers by a reverse
transcriptase Superscript M (Invitrogen). PCR was perfbrmed with GoTaq green master mix
(Promega) in the condition fbr 45 cycles at 940C fbr 30 s, 580C fbr 30 s, 720C for 45 s, using
reverse transcribed cDNA as a template wnh a sense and an antisense primers (Table 3) based on
the nucleotide sequence of mouse SAP155 (GenBank Accession No: AB037890) reported by
lsono et al. (2001). Each of the amplified DNA fragments was inserted into pT7Blue vector
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(Novagen). The nucleotide sequence was determined using an Applied Biosystems model 310
automated DNA sequencer.
Primers Aminoacidresidues
F5'ATCGCCAAGACTCACGAAGAT3'4-7
R5'CACAGCCCATCCACTTCCAT3'306-312
F5'AAT(IK]}AGCAGCAGCATCCCA3'185-191
R5'TCGGCCTTCCACTCTAGCAT3'588-594
F5'TGCACAAGATTCTTGT(K}TTATCG3'572-579
R5'CTTCATCAGGAGACTGAAATTCTC3'776-783
Table 3: The ptmers used for cDNA cloning
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5. SmmY AND CONCLUSIONS
   This dissertation has addressed the identification of a novel FSH-upregulated local factor,
NRGI, and its signaling mechanism underlying activation of germ cell proliferation in newt
(CIynops,pp2rzhognstei;) testis.
    ln the first part bfthe study, local factors secreted from somatic cells upon FSH treatment
were screened by using microarray analysis and neuregulinl (NRGI) was identified as a novel
FSH-upregulated clone. cDNAs encoding two different clones were isolated from newt testis.
The deduced amino acid sequences oftwo clones were 75% and 94% identical to .)VZenopus leavis
immunoglobulin (Ig)-type and cysteine-rich domain (CRD)-type NRGI, respectively, which had
distinct sequences in their N-terminal region but identical in their epidemial growth factor
(EGF)-like domain. mRNA expression of the two different clones was funher analyzed in
different sperrnatogenic stages and FSH-responsiveness in different cell types by semi-
quantitative and quantitative PCR analyses. It was shown that both clones were highly expressed
at spermatogonial stage than at spermatocyte stage and in vitro FSH treatment increased newt Ig-
NRGI (nlg-NRGI) mRNA expression markedly in somatic cells, vvhereas newt CRD-NRGI
(nCRD-NRGI) mRNA was only slightly increased by FSH. To elucidate the function of newt
NRGI (nNRGI), recombinant protein from the EGF-like domain of nNRGI (nNRGI-EGF)
known to mediate receptor signaling in marnmals and amphibians was produced and added into
the various culture systems. nNRGI-EGF promoted spermatogonial proliferation in organ
culture, in which nNRGI is not allowed to act on germ cells directly due to the existence of
blood-testis barrier fbrmed by Sertoli cells. ln re-aggregate cultures, in which blood-testis banier
was disrupted, nNRGI induced proliferation of spermatogonia either with or without somatic
cells. In addition, treatment ofthe cultures with the antibody against nNRGI caused remarkable
suppression of spermatogonial proliferation activated by FSH, indicating a pivotal role of
nNRGI in promoting spemiatogonial proliferation by both direct effect on spermatogonia and
indirect effect via somatic cells in newt testes.
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    ln the second part ofthe study, to identify the receptors responsible fbr the ]NRGI-induced
spermatogonial proliferation in newt testis, several inhibitors fbr each ErbB receptor family
member were added in both organ and re-aggregate culture. The data revealed the inhibitors fbr
ErbB2 or ErbB4 markedly suppressed the number of proliferated germ cells induced by nNRGI
and FSH, indicating that both ErbB2 and ErbB4 are activated by nNRGI. Expression studies of
ErbB2 and ErbB4 in diffbrent spermatogenic stages and cell types by using immunoblotting
revealed their expression in both somatic and gerrn cells at all the spermatogenic stages from
early spemiatogonial to primary spermatocyte. Since ligand binding to ErbB receptors induces
the formation of homo- or hetero-dimers, vvhich leads to the activation of diflierent signaling
pathways, such as phosphatidylinositol-3 kinase (PBK) or mitogen-activated protein kinase
(MAPK), the signaling pathway ofErbB2 and ErbB4 receptors was further analyzed by using
specific inhibitors in response to nNRGI stimuladon. The results showed PI3K inhibitor was
more efficient than MAPK inhibitor to repress nNRGI-induced spermatogonial proliferation.
Thus, nNRGI can promote spermatogonial proliferation by binding to ErbB4, which induces the
fbrrnation of ErbB4ZErbB4 homo- or ErbB41ErbB2 hetero-dimers, leading to the activation of
PI3K pathway in newt testis.
    ln the last part ofthe study, to further understand the mechanism of NRGIIErbB signaling
in the proliferation of sperrnatogonia, the proteins or molecules interacting with ErbB2 or ErbB4
receptor were screened by using matrix assisted laser desorption-time of fiight-mass
spectrometry (MALDI-TOF-MS) or electron-spray ionization (ESI). Spliceosome associated
protein 155 (SAP 155/SF3Bi55), a component of the U2 small nuclear ribonucleoprotein, was
identified as a protein interacting with ErbB4. A partial cDNA was isolated approximately 2.7-
kb in length encoding 930 amino acid residue homologous to mouse SAPI55. Comparison ofthe
amino acid sequence of newt SAP155 with its homologues in the N-terminal region and C-
terminal region revealed that the N-terminal region contains a cluster of TP-dipeptide motifs and
a domain containing RWDETP repeag while the C-terminal region showed significant similarity
to PR65 subunit of protein phosphatase 2A Immunoblotting in different spermatogenic stages
and cell types showed that newt SAPI55 was expressed in gemi cells at all spermatogenic stages.
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However, co-immunopreciphation of SAPI55 with ErbB4 antibody as well as the reciprocal co-
irnmunoprecipitation demonstrated their interaction only in primary spermatocyte stage,
suggesting that SAP155-ErbB4 binding may be linked to the downregulation of the
spermatogonial proliferation in primary spermatocyte stage.
    Reproduction is one of the most important phenomenons in development. Since impaired
sperm production and function accounts fbr half the cases of infenility, improvement to our
knowledge on the molecular basis ofspermatogenesis could lead to treatments for male fertility.
ln this aspect this dissertation provides a new inside in the field of reproductive biology that
FSH induces the expression of nlg-NRGI in Sertoli cells and recombinant nNRGI activates
ErbB2 and ErbB4 receptors directly on sperrnatogonia as well as on somatic cells, which leads to
the signaling trough PI3K pathway and ultimately promote spermatogonial proliferation. The
findings in this dissertation may help to pave the way fbr understanding the mechanism of
spermatogenesis and hopefu11y may help to develop some specific therapies to restore fenility in
the future.
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